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This thesis will focus on the implementation of elective single embryo transfer (eSET). 
Use of eSET in clinical practice could reduce the twin pregnancy rate after in vitro 
fertilisation (IVF). Prevention of twin pregnancies is preferred because of the relation 
with increased morbidity and mortality for both the mother and neonates compared to 
singleton pregnancies. In this chapter, an introduction is given to subfertility, IVF and 
twin pregnancies. The implementation problem with eSET is discussed, as well as 
the systematic approach to encourage eSET use in clinical practice. This chapter will 
conclude with a description of the aims and outline of this thesis.
Subfertility and in vitro fertilisation
Subfertility is generally described as any form of reduced fertility with a prolonged time of 
unwanted non-conception. For couples of reproductive age, subfertility is an important 
health problem. The inability to have children has a significant impact on the couples’ 
quality of life and may cause reactions similar to the confrontation with a serious illness 
or loss of a relative.1-3 The worldwide prevalence of  subfertility is estimated to range 
from 4 to 30 percent, affecting approximately 80 million couples around the globe.4 
Many couples seek medical attention for subfertility and are assisted to conceive. 
An evaluation in the Netherlands revealed that 15% of all couples visit specialist 
 subfertility care during their reproductive life.5 Approximately two percent of all 
European infants is currently born after subfertility treatment.6 In vitro fertilisation, 
including intracytoplasmic sperm injection, is an important treatment option for 
subfertile couples and is often the final possibility to start a family.
An IVF treatment episode could consist of multiple cycles, because only a minority of 
all couples will become pregnant after one cycle. The current average pregnancy rate 
per IVF cycle in the Netherlands is about 24% and this is comparable with European 
results.6,7 Every IVF cycle composes of an ovarian stimulation phase, pick up of oocytes 
from the stimulated ovaries, fertilisation in the IVF lab of the oocytes and sperm, and 
finally the transfer of a number of embryos into the uterus. The number of embryos for 
transfer could vary depending on the number and quality of the available embryos. 
Preferences of the couple and physician, as well as local routines or reimbursement 
rules, also influence the decision for the number of embryos transferred. For instance, 
in the Netherlands three IVF cycles are reimbursed by the national healthcare system, 
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but only if a maximum of two embryos have been transferred. With the exception of two 
European countries, Belgium and Sweden, no legislation on compulsory transfer of 
only one embryo exists. 8,9 In most IVF clinics in the world, the decision for the number 
of embryos is taken in a process of shared decision-making between the couple and 
the IVF physician. 
Twin pregnancies and elective single embryo transfer
After IVF, twin pregnancies are a common feature; roughly a quarter of all pregnancies 
are multiples.6,10 Although twin pregnancies may be experienced as a success by some 
subfertile couples and professionals, they could also be considered as a side effect 
or even a complication of IVF.11,12 With twin pregnancies, mortality and morbidity levels 
are elevated for both the mother and neonates compared to singleton pregnancies. 
Examples of the higher maternal risks for complications associated with twin 
pregnancies compared to singleton pregnancies are: a doubled risk for pre- eclampsia 
and eclampsia, a 2.5-fold increase in risk for long hospital admittance during pregnancy 
and a doubled incidence of caesarean sections.13,14 For the neonates examples are a 
5-fold increase in foetal death and premature births and a 4-fold increase in (very) low 
birth weight.12,14-22 The long term consequences of the complications vary, but could 
result in life-long negative impact on the quality of life.22,23 Moreover, these  complications 
of twin pregnancies after IVF cause substantial use of medical facilities and therefore 
influence health care budgets.24,25 The risks of twin pregnancies should therefore be 
seriously considered when managing subfertility.
Prevention of twin pregnancies after IVF is fairly easy to accomplish. Couples and 
 professionals could decide to transfer only one embryo, even if more are available. 
This use of eSET will reduce the incidence of twin pregnancies to 0-1%.26-28 However, 
use of eSET may be disadvantageous as well and could result in a lower pregnancy 
rate per IVF cycle, especially in an unselected population.29-31 This creates for the 
decision for the number of embryos transferred, a difficult balance between maintaining 
an acceptable pregnancy rate and the prevention of twins. For couples, the decision 
for eSET will reduce the risk of twin pregnancies but might also imply an increased 
probability to finally end up with no pregnancy at all.
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Implementation of elective single embryo transfer 
in clinical practice
Implementation of eSET in clinical practice has not been very successful so far. 
Although initiatives were launched to stimulate eSET use11, the single embryo transfer 
rate in Europe in 2004 was only 19% of all IVF cycles.6 This lack of spontaneous 
 implementation is not a unique feature at all. Grol and others describe that it is essential 
to use a systematic approach to promote practice of new innovations, guidelines or 
therapeutic options (such as eSET) in clinical practice.32,33 This systematic approach 
should consist of the following steps: acquiring insight in current practice;  identification 
of potential determinants (characteristics that predict adherence or non adherence 
to the option that should be implemented); analysis of barriers and facilitators for 
use of the preferred option in clinical practice: development of an implementation 
strategy (based on the barriers and facilitators) and finally, a thorough evaluation of 
the  implementation strategy. In this thesis this systematic approach will be used to 
attempt to encourage implementation of eSET in clinical practice and this mainly 
involves the decision-making process for the number of embryos transferred after IVF.
Aim and outline of this thesis
Main aim of this thesis will be to develop and evaluate a strategy to encourage eSET 
use. The first step described in this thesis is to evaluate current practice regarding 
eSET use and to assess barriers and facilitators for eSET use among both couples 
and professionals. With the results of this evaluation, a strategy for the implementation 
of eSET will be developed and evaluated for effectiveness and costs in a randomized 
controlled trial. Additionally, we will assess the implementation process itself. 
Chapter 2 will address the measurement of the eSET use in clinical practice and the 
identification of determinants for eSET and double embryo transfer among couples that 
had undergone IVF. Chapter 3 will deal with an evaluation of the literature about potential 
barriers and facilitators for eSET use according to two theoretical models.34,35 The next 
step will be to identify actual barriers and facilitators for eSET use among patients as 
well as professionals. Therefore, chapter 4 will illustrate a qualitative exploration of 
actual barriers and facilitators for eSET use, using face to face interviews among IVF 
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professionals and focus group interviews among IVF couples. Chapter 5 will describe 
the quantification of the previous identified barriers and facilitators of professionals 
and the classification of factors that could predict the willingness of IVF professionals 
to perform eSET. With the identified barriers a tailored multifaceted implementation 
strategy for eSET is developed. In chapter 6 the development of a main element of this 
strategy, a decision aid (DA) for the number of embryos transferred, will be presented. 
The evaluation of the multifaceted strategy through a randomised controlled trial will be 
presented in chapter 7. We evaluate the effect of the strategy on the number of embryos 
transferred, on costs reduction and on decision-making outcomes (for instance levels 
of empowerment, anxiety and depression). Chapter 8 will reveal the results of a 
process-evaluation and in particular the elements of the  multifaceted  implementation 
strategy that seem most influential as well as the experiences of couples who had 
undergone the implementation strategy. Overall conclusions and noticeable results will 
be discussed in the general discussion in chapter 9. 
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Abstract 
BACKGROUND Some 84% of all European in vitro fertilisation (IVF) and intra-
cytoplasmatic sperm injection (ICSI) cycles is performed with the transfer of more than 
1 embryo, with 22% resulting in twin pregnancies. At many centres, the choice for one 
or more embryos is made through a shared decision-making process. To reduce the 
twin rate in a twin prone population by increasing the use of elective single embryo 
transfer (eSET), it is important to identify which objective patient factors are related to 
the choice for double embryo transfer (DET) and eSET. Therefore, the aim of this study 
was to identify determinants related to the choice for the transfer of eSET or DET in a 
twin prone population. 
METHODS A retrospective study was performed on 477 twin prone couples at 
2 Dutch IVF centres. We collected data on possible objective patient determinants, and 
a  multivariate logistic regression analysis was performed to determine the impact of 
these determinants on the decision for DET. 
RESULTS Of the twin prone couples, 61% opted for DET in their first IVF/ICSI cycle. 
Within the multivariate analysis, two objective patient determinants acted as a risk 
factor for the choice of DET - a lower number of available embryos (p=0.03) and a 
previous ongoing pregnancy after IVF/ICSI (p=0.04). The explained variance of the 
determinants was 3%. 
CONCLUSIONS In twin prone couples, 61% still opted for DET in their first IVF/ICSI 
cycle. We identified 2 objective patient determinants for DET, but with an explained 
variance of only 3%. Therefore, further research is necessary to identify barriers and 
facilitators for eSET at both the level of the couples and clinicians. 
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Introduction 
In Europe, 84% of all cycles with in vitro fertilisation (IVF) and intracytoplasmatic sperm 
injection (ICSI) are performed with the transfer of 2 or more embryos.1 This results 
in a 22% twin delivery rate after IVF/ICSI. Twin pregnancies have higher morbidity 
and mortality rates for both mother and child compared to singleton pregnancies.2-5 
Consequently, the medical costs for twin pregnancies are approximately €10,000 
higher per pregnancy, and even e30,000 higher if life-long costs for handicaps are 
included.6,7 For these reasons, twin pregnancies are increasingly regarded as an 
undesirable medical result instead of a success.8,9
Elective single embryo transfer (eSET) is the key to reducing the number of twin 
pregnancies in IVF and ICSI 10-16, but could also result in lower pregnancy rates in an 
unselected population.17,18 Previous randomised studies evaluating clinical outcome 
after eSET and double embryo transfer (DET) have been performed in couples with 
a good prospect for pregnancy and at high risk for a twin - relatively young females 
in their first IVF/ICSI cycle with a sufficient number of embryos of good quality.12,13,15,19 
For these couples in particular, the twinning rate can be reduced through a high use of 
eSET, but this should be performed without compromising the patients’ autonomy to 
make their own medical decisions.11,20
Most European IVF centres have no strict protocol for the number of embryos to be 
transferred, and apart from Sweden and Belgium, no national legislation systems for 
eSET exists. Consequently, the decision on the amount of embryos to be transferred 
relies on the process of shared decision-making between the professional and the 
couple. In many European clinics, it is common practice that the couple is strongly 
involved in this decision-making process; the couples’ input is at least as important as 
the clinician’s point of view, and often the couple makes the final decision. Therefore, 
if we want to reduce the twinning rate through a higher use of eSET, we need to obtain 
insight into the decision-making process of the couple.21 A first step would be the 
identification of objective determinants related to the choice of one or two embryos.
The need to identify such determinants exists especially in the twin prone population. 
Within this group, we could expect that the initial intention would be to perform eSET, but 
it seems that, frequently, DET is performed instead. Identification of the  determinants 
Chapter 2
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related to DET enables professionals to recognize couples ‘at risk’ of transferring more 
than one embryo, and it will help the professional to focus on those couples that need 
DET. We could expect such patient-related determinants at a demographic level, such 
as social economic status or type of health insurance, and at the level of reproductive 
characteristics, such as previous pregnancy-related complications, treatment cycle 
features or experience with previous subfertility treatments.
Therefore, the aim of this study was to identify objective patient determinants related 
to the choice for DET in IVF/ICSI within twin prone couples, and to determine the 
importance of those determinants on the decision.
Methods 
Study population and setting 
A retrospective observational study was performed. Data were obtained from couples 
that had undergone IVF or ICSI in 2 of the 13 IVF centres in the Netherlands (Eindhoven 
and Nijmegen) in 2005. We selected a twin prone population for our analysis, and used 
similar inclusion criteria as previously published trials on eSET success rates.12-16,19,22 
The inclusion criteria were: a first IVF/ICSI cycle ever or a first cycle after a previous 
successful IVF/ICSI treatment, female age <40 years at ovum pick-up, and a minimum 
of 2 embryos available at the time of embryo transfer with at least 1 embryo of excellent 
or good quality. Embryos of these qualities were defined by no or <10% fragmentation.23
In both the participating IVF centres, the decision-making process for eSET or DET 
occurs before the start of the hormonal downregulation. This moment has been 
chosen to ensure that the couple has enough time to inform themselves and to make 
a thorough decision without the effects of hormonal stimulation or the pressure of 
an imminent embryo transfer. Couples and clinicians decide between eSET and DET, 
or the option to transfer 1 or 2 embryos depending on the quality of the available 
embryos.
Data collection 
We performed a literature search for patient determinants that might have an impact 
on the choice for eSET or DET in our twin prone population. As potential demographic 
Determinants of the choice for single or double embryo transfer in twin prone couples
23
 determinants, female age, monthly family income and state of insurance were 
suggested by the literature.24-26 Potential reproductive determinants suggested were: 
type of subfertility treatment (IVF or ICSI), previous ongoing pregnancy after IVF/ICSI, 
primary or secondary subfertility, maternal and paternal offspring, number of previous 
ectopic pregnancies or miscarriages, duration of subfertility, and the number of 
embryos available for transfer.20,27-31
Data on the demographic and reproductive determinants mentioned above were 
obtained from the IVF-databases and individual medical records of the two participating 
IVF centres. Unfortunately, three variables (insurance, maternal parity, paternal offspring) 
could only be obtained from one of the hospitals (Nijmegen). Monthly family income 
was calculated with a national database containing post code linked to fiscal income. 
32 For this study population, we assessed the eSET and DET prevalences as well as the 
subsequent treatment outcomes in the first and second fresh IVF/ICSI treatment cycles.
Statistical analysis 
All possible patient determinants were tested for univariate relationship with the 
choice for eSET or DET; binominal and categorical data were analysed by the χ2-test. 
The Mann-Whitney U-test was used to test continuous data. Variables with p values 
≤0.20 were found to be eligible for multivariate binary logistic regression analysis 
using the forward-likelihood-ratio method. In the multivariate analysis, we expressed 
the choice for DET as the dependent variable. Within the model, we corrected for the 
hospital of treatment as a confounder. A p value <0.05 was considered significant. 
The statistical analyses were performed with SPSS (Statistical Products Services and 
Solutions), version 14.0.1 (Chicago, IL, USA).
Results 
eSET and DET prevalence in the first and second IVF/ICSI cycle 
In 2005, a total of 894 couples underwent a first IVF/ICSI treatment cycle at the IVF 
centres in Nijmegen and Eindhoven. Of these couples, 477 (53%) met the inclusion 
criteria for twin prone couples (Figure 1). In 187 couples, eSET had been performed 
(39%), while 290 couples (61%) had DET (Table I). In total, 165 couples (35%) attained 
an ongoing pregnancy after the first embryo transfer. The ongoing pregnancy rate 
Chapter 2
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Figure 1  Study enrolment
Assessed for eligibility
•  First cycle in 2005 
N=894
Excluded
•  Age >40 
N=42 (5%)
•  <2 embryos for transfer 
N=192 (22%)
•  Did not meet embryo 
quality criteria 
N=183 (20%)
Included in study
N=477 (53%)
   eSET   DET
 n % 95% CI (%) n % 95% CI (%) P value 
Embryo transfer 187 39 (34.9 – 43.7) 290 61 (56.4 – 65.1) 
 
Ongoing pregnancies* 45 24 (18.5 – 30.7) 120 41 (35.9 – 47.1) <0.001
(% per ET)
 
Multiple pregnancies 0 0 - 30 25 (18.1 – 33.5) <0.001
(% per ongoing pregnancy) 
* > 12 weeks gestation
eSET = elective Single Embryo Transfer; DET = Double Embryo Transfer;
95% CI = 95% Confidence Interval
 
Table I  Choice for eSET and DET and clinical outcome in the first  
IVF/ICSI treatment cycle
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differed significantly between the eSET and DET group (24 versus 41%, respectively; 
p<0.001). The rate of multiple pregnancies was significantly different as well. While 
there were no multiple pregnancies in the eSET group, the 30 multiple pregnancies were 
all after DET (25%). Twenty-nine were twin pregnancies and one triplet pregnancy.
Of the 312 couples that did not conceive after the first attempt, 142 underwent a 
second IVF/ICSI cycle, and again had a minimum of 2 embryos available with at least 
one of good or excellent quality. Only 23 of these couples (16%) performed eSET in 
this second cycle.
Determinants associated with eSET or DET in the first cycle 
Univariate analysis of the demographic determinants in relation to the choice for eSET 
or DET revealed that only maternal age had a p value ≤0.20 (Table II). Monthly income 
and type of insurance showed higher p values and were not eligible for multivariate 
analysis. 
Regarding the reproductive determinants in relation to the choice for DET, univariate 
analysis identified 4 determinants with p≤0.20, and these were eligible for multivariate 
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  eSET (95% CI) DET (95% CI) P value
Age in years  Mean: 32.4 Mean: 33.0 
0.067
(n = 477)  (26 – 38.3) (24 - 40) 
 
Monthly family income  Mean: 2055 Mean: 2024 
0.818
in Euros (n = 350)  (1273 - 2938) (1200 - 3193)
 
Insurance private 43% (31 - 55%) 57% (45 - 69%) 
0.921
(n = 234) public health 43% (36 - 51%) 57% (49 - 64%) 
eSET = elective Single Embryo Transfer; DET = Double Embryo Transfer; 
95% CI = 95% Confidence Interval
 
Table II  Demographic characteristics associated with the decision  
between eSET and DET: Univariate analysis
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  eSET (95% CI) DET (95% CI) P value
IVF/ICSI IVF 42% (36 - 48%) 58% (52 - 64%) 
(n = 477) ICSI 36% (30 - 42%) 64% (58 - 70%) 0.179 
 
Type of fertility  IVF 42% (36 - 48%) 58% (52 - 64%)
treatment ICSI (Fresh semen) 40% (33 - 48%) 60% (52 - 67%)
(n = 436) ICSI (MESA/PESA) 32% (19 - 48%) 68% (52 - 81%) 0.468
 
Previous successful  no 41% (37 - 46%) 59% (54 - 64%)
IVF/ICSI yes 30% (21 - 40%) 70% (60 - 79%) 0.049
(n = 477)  
Type of Infertility  primary 41% (36 - 47%) 59% (53 - 64%)
(n = 452) secondary 36% (29 - 44%) 64% (56 - 71%) 0.338
 
Maternal parity   0 42% (37 - 48%) 58% (52 - 63%)
(n = 350) 1 or more 43% (33 - 53%) 57% (47 - 67%) 0.907
Paternal offspring  0 45% (38 - 52%) 55% (48 - 62%)
(n = 268) 1 or more 38% (29 - 48%) 62% (52 - 71%) 0.302
 
Ectopic pregnancy   0 44% (38 - 50%) 56% (51 - 62%)
or early miscarriage* 1 or more 36% (26 - 47%) 64% (53 - 74%) 0.189
(n = 380)  
Duration of infertility    Mean 2.8 Mean 2.7
in years (n = 430)  (0 –6.9) (0.2 – 7.0) 
0.343
 
Number of embryos    Mean 7.0 Mean 6.3
(n = 477)  (2 - 17) (2 – 17.5) 
0.005
* Up to 16 weeks of pregnancy
eSET = elective Single Embryo Transfer; DET = Double Embryo Transfer;  
95% CI = 95% Confidence Interval
Table III  Reproductive characteristics associated with the decision  
between eSET and DET: Univariate analysis
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analysis: a previous ongoing pregnancy after IVF or ICSI, the number of embryos 
available for transfer, the type of infertility treatment (IVF or ICSI), and the number of 
previous ectopic pregnancies or miscarriages (Table III). 
Within the multivariate analysis (Table IV), two of the five potential patient determinants 
from the univariate analyses seem to be of importance. A lower number of embryos 
available for transfer were associated with a significantly higher chance of performing 
DET (p=0.03). In addition, a previous ongoing pregnancy after IVF/ICSI was related 
to an increased chance of choosing DET (p=0.04). The explained variance of the 2 
determinants for the final regression model was 3%. 
Discussion 
This study reports on patient determinants correlating with the choice for DET in twin 
prone couples. We revealed that a lower number of embryos available for transfer and 
a previous pregnancy after IVF/ICSI were determinants for choosing DET. However, the 
explained variance of these two variables was only 3%. In twin prone couples, an eSET 
prevalence of only 39% in the first cycle and 16% in the second cycle was found. These 
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Variables B OR (95% CI) P value ‘Risk factor’ 
    for DET
Number of embryos
 
-0.05
 0.95 
0.03
 Less embryos
  (0.90 – 0.99)  available 
 
Previous pregnancy after  0.51 1.67 
0.04
 Previous
IVF/ICSI (0 = no, 1 = yes)  (1.01 – 2.78)  pregnancy
    after IVF/ICSI
R2 of three variables combined: 0.03
OR = Odds Ratio 95%; CI = 95% Confidence Interval; DET = Double Embryo Transfer; 
R2 = explained variance
Table IV  Chance of transferring two embryos, in multivariable logistic 
regression analysis
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relatively low eSET rates, combined with the fact that 25% of all ongoing pregnancies 
after a first DET cycle were multiple pregnancies, emphasises the need to focus the 
decision-making process around the amount of embryos for transfer.
The first identified determinant demonstrates that twin prone couples with fewer 
embryos available for transfer are more likely to undergo DET compared to couples 
with more available embryos. This seems logical, and could represent the clinician’s 
accurate clinical estimation of the possibility of pregnancy before the start of treatment. 
However, it could also be seen as remarkable because in the participating clinics, 
it is custom to decide for eSET or DET even before the hormonal downregulation 
regimen is started. At that time, the number of available embryos is obviously not yet 
known. Apparently, clinicians and couples change their decision from eSET to DET if 
the amount and quality of embryos suggest a less favourable chance for pregnancy.33 
On the other hand, couples that have chosen DET and then turn out to a have a 
high number of embryos probably do not perform eSET instead. This difference might 
suggest that professionals and couples still focus mainly on the chance to become 
pregnant instead of the risk for twins.
The second determinant related to the choice for DET is a previous ongoing pregnancy 
after IVF/ICSI. The effect of this determinant is opposite to what could have been 
expected. Clinicians would see a previous pregnancy after IVF/ICSI as a positive 
parameter for a higher chance of success, and hence a motive to perform eSET. 
However, in this study, a previous pregnancy after IVF/ICSI is actually a determinant for 
DET. A possible explanation for this is that couples with a previous positive experience 
with DET do not consider eSET as an option. The previous treatment had a positive 
result, so they have confidence in the DET regimen. Another possibility is that the 
experience of going through an IVF or ICSI treatment may have been a burden for 
the couple. Given the fact that with eSET more cycles may be necessary to obtain a 
positive result12, couples might resist undergoing the transfer of only 1 embryo.
In this study of twin prone couples, a higher female age is not significantly associated 
with DET. This finding seems surprising since even in our selected population of women 
<40 years, differences in eSET rate could have been expected between couples with 
older and younger women. Other studies reported that in unselected couples, older 
women preferred DET significantly.27,34
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The total explained variance of the selected patient determinants in the multivariate 
logistic regression model is only 3%. This indicates that the impact of objective 
patient determinants on the decision for DET was small. Apparently, other objective 
and subjective variables play an important role in the decision-making process for the 
amount of embryos for transfer.24 Potential factors that could have a substantial impact 
on the choice for eSET or DET could be lack of knowledge on twin-related compli-
cations27,34 and the desire for twins.28-30,35,36 In addition, cultural and legal differences 
between countries could play an important role, suggested by the differences in eSET 
use between countries.1 Therefore, additional research should be performed to gain 
an insight into the more subjective barriers and facilitators for eSET at the level of the 
patient, as well as at the level of the professionals.
In spite of our plea for increasing the (European) eSET rates in the twin prone 
population, it is important to consider that eSET should not be the option for every 
subfertile couple.11,20 In our opinion, optimal use of eSET consists of 3 domains: 
maximal twin reduction using eSET, maintaining an acceptable pregnancy rate, and 
a reasonably satisfied couple on completion of the treatment. For this reason it is 
important to ensure that the couple is part of the decision-making process. More 
research is needed to define preferences of the couple and physician at these domains, 
for instance by interviews, focus groups or trade-off scenarios.37 Furthermore, the use 
of eSET will result in more singleton pregnancies, but this might not represent the 
desirable outcome for all patients. Some IVF/ICSI couples have a preference for a twin 
pregnancy29,35, and this wish should not be neglected if it is based on sufficient and 
correct information about twin risks.
In conclusion, 61% of twin prone couples still opt for DET in their first IVF/ICSI cycle. 
We identified two objective patient determinants for DET in a twin prone population: 
a lower number of embryos available for transfer and a previous ongoing pregnancy 
after IVF/ICSI. However, the explained variance of these determinants was only 3%. 
Therefore, further research will be necessary to identify barriers and facilitators for 
eSET at both the level of the couples and clinicians.
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What do we know?
Twin pregnancies are no longer considered to be a successful outcome in IVF and 
ICSI, and eSET is the most effective intervention to prevent twins. Although this is 
acknowledged by many professionals and international societies, in Europe the 
percentage of SET use remains stable around a disappointing 15%. The majority of 
clinics still have a transfer with multiple embryos as a standard method. Apparently it 
is very difficult to implement eSET in clinical practice. The question is where barriers 
exist that cause this implementation difficulty.
What do we need to know?
According to implementation theory, we can expect potential barriers for the 
 implementation of eSET at many levels, such as clinicians, couples or context. 
Because of all these barriers, it will be necessary to design a thorough, evidence-
based strategy to implement eSET successfully in daily practice. The first step for the 
design of such a strategy is to identify all potential barriers for eSET at all relevant 
levels.
What should we do?
The barriers described in this chapter can be used for the design of an evidence-
based implementation strategy for eSET. However, the list of potential barriers is 
extensive and until now it is not clear what barriers have the most impact compared 
with others. Before a strategy is designed, it will be necessary to assess the barriers 
prevailing in each society. This way, we can assure that the strategy will be useful for 
the applicable situation. Moreover, other still undiscovered barriers could also play 
a role. We would therefore strongly recommend further research that focuses on the 
multifactorial aspects of this implementation problem.
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Introduction
A twin pregnancy after in vitro fertilization (IVF) and intracytoplasmic sperm injection 
(ICSI) is no longer considered to be a successful outcome.1 There is extensive evidence 
on the higher incidence of twin-related complications for both mothers and neonates2-12 
and the related medical costs of these complications have a substantial impact on 
healthcare budgets.13,14 Elective single embryo transfer (eSET) is the key intervention 
to reduce the twin rate dramatically.15 When performed in a suitable population, 
eSET will maintain an acceptable pregnancy rate per cycle.16-21 For this reason, the 
use of eSET has gained increasing attention and is supported by policymakers and 
international organizations as the preferred treatment option.1 However, in Europe the 
percentage of SET use remains stable around a disappointing 15% in recent years.22 
The majority of countries still have double embryo transfer (DET) as their standard 
method and some even transfer three embryos or more routinely. This demonstrates 
that apparently it remains difficult to implement eSET in clinical practice.
The problems with the implementation of eSET are not surprising at all. Difficulties with 
the implementation of innovations, like eSET, are a common phenomenon in clinical 
practice.23 Complete and spontaneous dissemination of a new therapeutic intervention 
is rare and this could have numerous reasons. For the implementation of eSET we can 
expect potential barriers at many levels. For instance, the decision for the number of 
embryos transferred is often taken by multiple people instead of only one. This means 
that even if you convince the professionals to perform eSET, the couple might decide 
to perform a transfer with multiple embryos instead. Another potential problem could 
be that eSET in an unselected or older population might result in a drop in pregnancy 
rate and therefore policymakers will be very careful with the implementation of eSET for 
all couples in their clinics. Another example could be that guidelines, reimbursement 
systems and legislation also have a great impact on eSET use.
Because we can expect many potential barriers for eSET at different levels, it will 
be necessary to design a thorough, evidence-based strategy to implement eSET 
successfully in daily practice.24,25 Without such a strategy it will be nearly impossible 
to increase the eSET use. The implementation strategy should be based on the 
barriers for eSET that exist at all different levels. In this chapter we will describe these 
potential barriers for eSET, according to theoretical domains of implementation theory 
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and literature on assisted reproductive technology (ART). The theoretical models 
demonstrate that barriers can exist at four domains.26,27
• Characteristics of the innovation
• Characteristics of the professionals
• Characteristics of the patient
• Characteristics of the context
In this chapter we will follow this structure to describe possible barriers for eSET. 
It is important to consider that within our description we will assume that no legislation 
for compelled eSET use exists and that couples and professionals take the decision 
for the number of embryos transferred through a process of shared decision-making. 
Furthermore, not all barriers mentioned within the theoretical models were identified 
through clinical studies. Because of lack of evidence, it was sometimes necessary 
to describe the barriers through interpretation of implementation theory or through 
barriers found with other implementation problems. When applicable, we will 
distinguish clearly within the paragraphs between barriers identified through clinical 
studies (indicated as “evidence-based” barriers) and barriers found by means of 
 interpretation of implementation theory (indicated as “theory-based” barriers).
The barriers for eSET described in this chapter give an overview of potential barriers 
for implementation of eSET in daily practice. However, the setting of the IVF/ICSI 
treatment can vary greatly between countries and even clinics. In every setting 
other barriers could play an essential role. Therefore, to design a local, national or 
international implementation strategy, it is important to analyze the barriers according 
to the local specific setting. Although it is complicated to present a general set of the 
most important barriers, experiences in some countries do provide us with valuable 
information on eSET implementation. Consequently, we can end this chapter with a 
paragraph with suggestions to increase the eSET use in general.
Characteristics of eSET
For optimal implementation, certain aspects of the innovation itself that has to be 
implemented can impede implementation. Also for eSET, characteristics might act as 
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an extra obstacle for the acceptance of eSET as a standard. The following barriers 
could be of importance for eSET implementation.
Elective SET could cause a decrease in pregnancy rate per cycle 
(evidence-based)
The use of eSET can cause a reduction in live birth rate per cycle compared with the 
transfer of multiple embryos18, especially in an unselected population.20 To obtain an 
equal pregnancy rate compared with a multiple embryo transfer regimen, more cycles 
may be necessary.17,19 For patients lower pregnancy rates are difficult to accept28, 
especially since for some patients the number of cycles they can endure is limited.29 
If couples or professionals focus on the change for pregnancy per cycle instead of 
pregnancy rates per couple or per time period, this fact might act as a barrier for eSET 
implementation.
Furthermore, when eSET is the standard or even compelled for all patients, couples 
with an initial lower chance for pregnancy will pay the price for the prevention of twin 
pregnancies in other couples with better prospects. The concern that some couples 
are withheld from an acceptable chance for pregnancy is a barrier to using eSET as 
a standard in clinical practice.
A substantial part of twin pregnancies end up with minor or no 
complications (evidence-based)
The most important feature of eSET is the prevention of twin pregnancies. Although 
there is a lot of evidence on complications for mothers and neonates associated 
with twin pregnancies 30-33, complications only occur in the minority of cases.8,34 
This could be a barrier for eSET implementation. If the higher risks with twins are 
not acknowledged as a serious problem, clinicians or couples will probably not be 
motivated for eSET.
Lack of a sufficient cryopreservation program (evidence-based)
The implementation of eSET is facilitated through a sufficient cryopreservation 
program. With a successful freezing protocol, the possible reduction in pregnancy 
rate per fresh cycle, as described above, could be compensated for.19 Some even 
state that a good freezing program is a necessity for the general use of eSET and that 
better cumulative results with frozen-thawed embryos are possible.21 If no sufficient 
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cryopreservation program exists, or when the success rates of frozen-thawed embryos 
are disappointing, this is a potential barrier for eSET.
Lack of prognostic models or selection criteria for eSET (evidence-based)
No generally accepted, strict prognostic models are available for the selection of 
patients eligible for eSET. For couples and professionals it is very important to be 
able to predict the chance of pregnancy before the choice for the number of embryos 
to transfer is made. If this chance is considered to be low, the transfer of only one 
embryo might impede the patient of a reasonable chance of success and DET is 
probably a better option. The inability to select the right couples for eSET might 
stimulate couples and professionals to “play it safe” and choose to transfer multiple 
embryos. Consequently, this could be a barrier for eSET use.
Disadvantages of eSET are easier to recognize for couples and clinicians 
compared with the advantages (theory-based)
A potential barrier for eSET implementation is that the negative results of the 
 implementation of eSET (lower pregnancy rate per cycle for some couples) become 
visible immediately and affects the individual couple directly (they fail to become 
pregnant). The positive effect of eSET implementation, twin reduction, takes longer 
to become apparent and for the couple this might not make a very big difference 
(both a singleton and twin is a pregnancy and therefore a success). For clinicians and 
policymakers this creates a difficult situation. In the transition phase between multiple 
embryo transfer and eSET, patients and professionals might focus on the decreasing 
pregnancy rates per couple, instead of the also decreasing twin rate for the whole 
population and the unchanged overall success rate.
Characteristics of the IVF professional
In the process of shared decision-making for eSET or multiple embryo transfer between 
patients and clinicians, the doctor plays an important role. The clinician is often the 
only one taking part in the decision-making process with a rational instead of emotional 
involvement. During the counselling process, the professionals’ opinion or advice could 
greatly influence the final decision for the number of embryos to transfer. Therefore, 
factors related to the clinical professional could impede the use of eSET in practice.
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Doubts about the necessity for eSET (evidence-based)
Not all professionals feel the need for the prevention of twin pregnancies and therefore 
are not stimulated to transfer only one embryo. They are apparently not convinced 
or willing to define twin pregnancies as a complication of IVF and ICSI.34,35 Even 
though (inter)national organizations classified multiple pregnancies as a negative 
result instead of a success after IVF/ICSI1, this did not convince all professionals. 
A potential reason for this is that fertility specialists often do not see the patient after 
the pregnancy test has turned positive. The complications of twin pregnancies are 
regularly dealt with by other clinicians. If fertility clinicians do not feel the need to 
decrease the twin rate after IVF/ICSI, they will probably advise to transfer multiple 
embryos to maximize the chance for pregnancy per cycle. This behaviour would be a 
barrier to eSET use.
Insufficient counselling skills (evidence-based)
Good communicating skills are required to be able to discuss all aspects of the 
choice for one or more embryos in a thorough and unbiased way.36 Often couples start 
with IVF and actually desire a twin pregnancy, but change their mind after thorough 
counselling.28,30-32 To discuss the twin-related risks and the pregnancy rates of eSET 
and multiple embryo transfer, while at the same time ensure the couples’ freedom of 
choice, is an ability that not all clinicians master immediately and probably comes with 
experience. Without this ability the couples might not be informed correctly and miss 
out on essential information. This could be a barrier for the use of eSET.
Lack of knowledge of professionals on twin risks and eSET success rates 
(theory-based)
To make a good decision, patients and their clinicians need the appropriate 
information. It is primarily the professionals’ responsibility to provide the couple with 
all the necessary facts. Without the essential knowledge on twin-related risks and 
pregnancy rates related to the number of embryos transferred, it is impossible to 
make a thorough decision. If professionals do not possess sufficient knowledge this 
could be a barrier to eSET.
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Characteristics of the couples undergoing IVF/ICSI
In most clinical settings, the couples have an important part in the decision for the 
number of embryos to transfer. Moreover, in a lot of settings the patients make the final 
decision and the doctor plays an advising role. Therefore, characteristics of couples 
undergoing IVF/ICSI could impede the general use of eSET in clinical practice.
Female age in the population undergoing IVF/ICSI (evidence-based)
Female age is the most important predictor of success in ART. Younger females 
achieve higher pregnancy rates compared to couples with an older woman.37-39 
If the IVF/ICSI treatment is applied in a population with relatively older females, this 
could imply that the pregnancy rates will be lower compared to a population where 
the females are relatively younger. In such an older population it will be more difficult 
to perform eSET, because the success rate might fall below an acceptable level. 
For this reason, a higher female age is an important reason to transfer multiple 
embryos. The differences in eSET use between countries might be explained by the 
fact that some countries perform IVF earlier compared with others.
Considering a twin to be a successful outcome (evidence-based)
Patients have difficulty in seeing a twin as a complication instead of a success. Most 
couples that undergo IVF/ICSI have been trying to conceive for an extensive time 
period and often already have a history of failed attempts with other therapeutic 
options like medication or insemination. The patients that finally decide to undergo 
IVF or ICSI have a strong desire for children and regularly see a twin pregnancy as a 
success instead of a complication.30,32,33,40 In addition, patients frequently wish for more 
than one child to complete their family and in their view a twin pregnancy immediately 
fulfils this wish.41 To realize this “ideal” scenario, the transfer of one embryo is not the 
best option and eSET could only make it take longer before this goal is achieved. 
When couples simply do not think of twins as a complication, this is a barrier for eSET 
use. Furthermore, if couples have personal experience with twins and this experience 
was not negative, this could make it difficult for them to see a twin pregnancy as a 
complication instead of a success.
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Insufficient knowledge of patients on twin risks and eSET success rates 
(evidence-based)
The possession of accurate information is essential to be able to make a thorough 
decision about the number of embryos for transfer. If couples do not have the right 
information, it is impossible for them to make a sufficient consideration.42 This problem 
of deficiency of the proper information has three potential causes. First, patients 
frequently have difficulties with dealing with probabilities and chances. Problems 
with processing percentages, ratios and statistical numbers are common and could 
complicate the decision-making process.43,44 Second, the individual twin-related 
risks, when presented to the couple, might not look that impressive. Couples often 
feel such a strong desire to have children, that during counselling they experience 
the twin-related risks percentages as less important and unimposing.45 A third aspect 
could be the problem that couples might simply not be provided with the information 
by their IVF professionals. Possibly the professional does not feel responsible, or 
does not have the knowledge. The lack of information, or the inability to deal with the 
information, is a potential barrier to eSET. Couples will not be able to see the whole 
perspective and might just choose for the option that provides them with the maximal 
chance for pregnancy per cycle.
Couples might dread possible extra necessary cycles with eSET 
(theory-based)
The potential necessity of extra treatment cycles to maintain similar pregnancy rates 
compared with multiple embryo transfer regimens17,18,20,22, is a potential barrier to eSET. 
In particular patients without experience of IVF or ICSI could be anxious about the 
burden of hormonal injections and the burden of the uncertainty about success or 
failure they will have to face with every cycle.
Ethical/religious barriers (theory-based)
If only a limited number of oocytes is fertilized, or when it is impossible to take 
advantage of cryopreservation, this will reduce the pregnancy rate remarkably.19 
This lower pregnancy rate could be a strong incentive to transfer more than one 
embryo. Some couples have ethical or religious objections against either fertilizing 
embryos they might not use, freezing embryos that possibly will not survive or to 
potentially create supernumerary embryos that might never be transferred. Therefore, 
this could impede implementation of eSET.
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Characteristics of the context in which IVF/ICSI 
is performed
Besides the characteristics of eSET itself and the people taking the decision for the 
number of embryos for transfer, the context of the choice for eSET or multiple embryo 
transfer could have significant impact on eSET implementation as well. If external 
conditions are not favourable for eSET, this might greatly influence the decision for the 
number of embryos for transfer.
Legislation for eSET or another form of compelled eSET (evidence-based)
Legislation or rules for compelled eSET are essential factors that have shown 
immense impact in countries where they were implemented. Evidently, when the use 
of eSET is compelled, it is not possible for couples or clinicians to choose a multiple 
embryo transfer regimen. This will increase the eSET rate remarkably.46 The process 
of decision-making is presumably non-existent when such legislation or compelled 
eSET rules are present. In that case, an implementation strategy with a focus on 
shared decision-making seems unnecessary. However, other identified barriers for 
eSET implementation are not completely insignificant. Questions on patient autonomy 
might be raised when couples lose the freedom to choose the number of embryos 
for transfer 15 and optimal implementation of eSET will only occur if acceptance is 
achieved at the patient level, even if legislation is present.47 
Legislation could also work the other way around. If legislation forbids the use of 
cryopreservation techniques or fertilization of possible supernumerary embryos, as is 
the case in Italy 48, this could actually impede the eSET use.
Reimbursement of IVF/ICSI cycles (evidence-based)
Couples are often billed for their IVF and ICSI treatment per cycle. The average costs 
per cycle vary greatly between countries, but regularly have a substantial impact on 
the couples’ financial situation. Especially when no reimbursement system exists or 
when a limited number of cycles are reimbursed, patients might have financial reasons 
to transfer more embryos to maximize their pregnancy chance per cycle.49
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Lack of clinical guidelines (evidence-based)
National guidelines, developed by societies of peer professionals, could facilitate 
the quality of care and suggest the appropriate treatment options for clinicians in 
the field. Unfortunately national subfertility guidelines are not commonly used50 and, 
except from a few innovative European countries, no guidelines exist to ensure the 
use of eSET.48  If no clinical guidelines are present, clinicians will feel free to decide 
on the number of embryos according to their own insight. As discussed before, some 
clinicians might not agree with the need for eSET and therefore use a multiple embryo 
transfer regimen. The lack of guidelines on the number of embryos for transfer could 
impede the use of eSET. However, even with existing clinical guidelines, this is no 
guarantee that they are strictly followed by everyone.51
Competition between clinics and commercial interest (theory-based)
In modern medicine it is becoming more and more accepted to publish yearly 
reports of ART results 22,49 With the implementation of eSET, clinicians could face a 
(slight) decrease in pregnancy rate per cycle.18 This potential decrease may well be 
commercially unappealing, especially when neighbouring clinics did not implement 
eSET and are able to maintain their success rates per cycle. When the differences in 
pregnancy rate are published, future patients might decide to go to the other clinic 
instead. The fear for potential loss of patient supply could be a barrier to eSET.
International differences in eSET use and the possibility to travel abroad 
(theory-based)
Considerable differences exist between countries in many aspects of subfertility 
treatment.22,49 Apart from technical differences in laboratory interventions, one could 
also observe different stimulation regimens, variation in oocyte aspiration protocols, 
availability of donated oocytes and especially the maximal number of embryo for 
transfer.48 These differences, combined with possible cultural and ethical variation 
could stimulate couples to travel abroad and undergo their subfertility treatment 
elsewhere. This might act as a barrier for eSET use, since it enables couples to 
escape a national eSET protocol and go for a multiple embryo transfer regimen 
instead. However, it is difficult to determine the magnitude of this problem, since no 
exact numbers for this phenomenon are yet demonstrated.
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Freedom of choice for the couples; shared decision-making or not? 
(theory-based)
In some clinics, couples are probably not really counselled or advised about the 
number of embryos for transfer. Instead, they are simply told how many embryos 
are going to be transferred. Even if the choice of number of embryos transferred is 
considered to be a process of shared decision-making, in practice this might turn out 
with a professional “strongly suggesting” a certain option. If this situation exists, it 
will be less effective to focus on barriers existing with the couples and more useful to 
focus on the barriers for eSET at the level of the doctors.
Suggestions to increase eSET use
In the paragraphs above we have demonstrated that many factors can affect the 
 implementation of eSET in daily clinical practice. A summary of the barriers mentioned 
is shown in Table 1. The barriers described can be used for the design of an evidence-
based implementation strategy for eSET. However, the list of potential barriers is 
extensive and until now it is not clear what barriers have the most impact compared 
with others. Before such a strategy is designed, it will be necessary to assess the own 
local setting, to be sure that the strategy will be useful for the applicable local, national 
or international situation. Moreover, other still undiscovered barriers could also play 
a role. We would therefore strongly recommend further research that focuses on the 
multifactorial aspects of this implementation problem.
It is important to consider that eSET should not be the option for every subfertile 
couple.35,34 In our opinion optimal use of eSET consists of three domains: maximal twin 
reduction through the use of eSET, maintaining an acceptable pregnancy rate and a 
reasonably satisfied couple when the treatment has been finished. Increasing the eSET 
use regardless of these domains is a bridge too far. For this reason it is important to 
make sure that the couple is part of the decision-making process. Nevertheless, even 
when we account for these three domains, we can still report suggestions to increase 
the eSET use. These suggestions have either shown their influence before or could be 
expected to result in a higher use of the eSET technique in general.
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Legislation or reimbursement system that stimulates eSET
Legislation for a form of compelled eSET use will increase the eSET rate significantly. 
In Europe there is experience with such a construction in Belgium and Sweden 
and the eSET use there is remarkably higher compared with other countries.15,46 
The experiences with the new systems in these two countries are promising. 
The development of the legislation system does require a lot of input and should be 
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 Elective SET could cause a decrease in pregnancy rate per cycle
A substantial part of twin pregnancies end up with minor or no complications
Lack of a sufficient cryopreservation program
Lack of prognostic models or selection criteria for eSET
Disadvantages of eSET are easier to recognize for couples and clinicians compared to
the advantages
Characteristics of the IVF professional
Doubts about the necessity for eSET
Insufficient counselling skills
Lack of knowledge of the professionals on twin risks and eSET success rates
Characteristics of the couples undergoing IVF/ICSI
Female age in the population undergoing IVF/ICSI
Considering a twin to be a successful outcome
 Insufficient knowledge of patients on twin risks and eSET success rates
Couples might dread possible extra necessary cycles with eSET
Ethical/religious barriers
Characteristics of the context in which IVF/ICSI are performed
Legislation for eSET or another form of compelled eSET
Reimbursement of IVF/ICSI cycles
Lack of clinical guidelines
Competition between clinics and commercial interest
International differences in eSET use and the possibility to travel abroad
Freedom of choice for the couples; shared decision-making or not?
Table 1  Barriers for eSET implementation
eSET = elective Single Embryo Transfer; ICSI = Intra Cytoplasmic Sper Injection;
IVF = in vitro fertilisation
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closely supervised by professionals. Obviously, it will take time and effort to convince 
policymakers to agree with the proposed rules and the development of the rules will 
involve supervision and extensive evaluation. Therefore we would suggest that, if 
legislation is considered, this is developed and supervised by IVF professionals or 
national professional societies.
A reimbursement system that stimulates eSET could also be very important for the 
implementation of eSET. If couples and professionals do not experience a financial 
incentive for multiple embryo transfer, this enables them to solely look at the medical 
aspects of eSET versus multiple embryo transfer. It is important to consider that an 
eSET regimen with potential extra treatment cycles is actually cost-effective and will 
reduce costs because of the prevention of the more expensive twin pregnancies.13
Maintaining higher pregnancy rates per cycle with eSET, through 
improvement of prognostic models, better embryo selection and enhanced 
cryopreservation protocols
If the difference in pregnancy rate per cycle between eSET and multiple embryo 
transfer could be reduced or even diminished, this will be an important facilitator for 
eSET implementation. The way to achieve this is probably through improvement of the 
ability to select the right couples for eSET, identifying the best embryos and to obtain 
better results with frozen-thawed embryos.
If we were able to select the appropriate couples for eSET and DET, we could prevent 
lower success rates previously reported in an unselected population.20  New prediction 
models have recently been published39,52, but none of them are generally accepted 
or have proven their value with eSET especially. The same situation is applicable 
with embryo selection. Identification of the ultimate “eSET embryo” would enable us 
to apply eSET only in the applicable population. Big differences between embryo 
analysis protocols exist and no clear definition of an embryo particularly suitable for 
eSET could be demonstrated yet. Recent literature did suggest new embryo selection 
criteria4, but it remains uncertain if these criteria can be broadly used.
Good cryopreservation results offer us a “bonus” with every fresh cycle.19 If we were 
able to improve the eSET success rates, with a cumulative pregnancy rate comparable 
with the results of multiple embryo transfer regimens, this will act positively on eSET 
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 implementation. The experiences with cryopreservation vary greatly between countries. 
The Nordic European countries have a tradition of good cryopreservation results, but 
until now these results could not be repeated in other countries or clinics.
Improvement of information provision
To increase eSET use, couples need to recognize the disadvantages of twin 
pregnancies and combine this with a realistic view on the pregnancy rates per cycle 
that come with eSET. It is vital that they are able to recognize that with possible extra 
cycles they maintain a similar chance for pregnancy compared to a multiple embryo 
transfer regimen with fewer cycles.17-19 If couples understand the complications 
associated with twins, this might result in a change of attitude in favour of eSET.31,33,53 
It will not be a simple task to ensure that couples receive the right information in a way 
they can grasp. Professionals need to invest time and effort in the counselling process 
and try to ensure their impartiality in the process of decision-making. Furthermore, to 
make this multifactorial problem understandable and comprehensible, patients will 
probably require a counselling tool, especially designed for this particular problem.42 
Standardization of presentation of clinical outcomes
Success in IVF and ICSI is not only defined by the live birth rate per cycle but is 
more a balance between high live birth rates with healthy babies and low numbers of 
multiple pregnancies with complications. Additionally, the factor time also might play 
an important role since for couples it is important not only to know if, but also when, 
they will become pregnant. Therefore, apart from the pregnancy rates per cycle, also 
total live birth rates, life birth rate per episode, twin rates, complication rates and the 
use of foetal reduction are very important outcome features. If clinics were to report 
all these aspects of their treatment results, this could act as a facilitator for eSET 
implementation. It enables couples and clinicians to base their decisions for eSET 
and DET on thorough evidence and it could also prevent policymakers from refraining 
from eSET implementation because of commercial reasons.
In conclusion, in this chapter we have tried to give an overview of possible barriers for 
eSET implementation in clinical practice. With this overview we hope that clinicians 
and policymakers will be able to assess their own setting and design their own strategy 
to implement eSET optimally. Only if this pathway is followed is it likely that we will be 
able to increase eSET use compared to the current disappointing plateau of 15%.22
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Abstract
BACKGROUND Elective single embryo transfer (eSET) enables the prevention of 
multiple pregnancies after in vitro fertilization (IVF). However, in Europe, the multiple 
pregnancy rate after IVF remains stable at ∼23%, with SET occurring in 15% of all IVF 
cycles. In most European clinics, the decision for the number of embryos transferred 
is established through a form of shared decision-making between patients and 
professionals. The aim of this study is to explore factors influencing this decision, in 
particular factors preventing eSET use. 
METHODS We performed explorative, semi-structured, in-depth interviews, based 
on two theoretical models. The interviews were performed among 19 Dutch IVF 
professionals and 20 patients who had just undergone IVF or were on the waiting list 
for IVF. The interviews were fully transcribed and two researchers independently scored 
the factors according to the models. 
RESULTS We identified a wide variety of factors, potentially influencing eSET use: 37 
with the professionals and 26 among the patients. Examples of factors mentioned by 
both patients and professionals were: uncertainty about the eSET technique, couples’ 
lack of knowledge about essential eSET aspects, absence of a reimbursement system 
which favours eSET, inadequate options to select couples suitable for eSET and inferior 
cryopreservation success rates. 
CONCLUSIONS This study demonstrates that both IVF professionals and patients 
identify numerous factors preventing eSET use in clinical practice. To estimate the 
impact of these factors identified, a quantitative confirmation and assessment of the 
magnitude of the effect is necessary. 
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Introduction
 
About one-third of all twin pregnancies are the result of in vitro fertilization (IVF) or intra-
cytoplasmic sperm injection (ICSI).1 Multiple pregnancies are associated with increased 
morbidity and mortality for both mothers and neonates compared with singleton 
pregnancies.2-4 The complications associated with multiple pregnancies also account 
for elevated costs.5,6 Elective single embryo transfer (eSET) enables us to prevent 
multiple pregnancies after IVF.7-11 However, eSET may result in a lower pregnancy rate 
per cycle, especially in an unselected population.12 For couples with a less favourable 
chance for pregnancy, twins may be seen as a success.13,14 It is therefore not surprising 
that the implementation of eSET in daily practice is not yet overwhelming. The multiple 
pregnancy rate after IVF in Europe remains stable at ∼23%, with an SET proportion of 
15% of all IVF cycles.15 
In Europe, no national legislation or compulsory protocols for eSET exist, with the 
exception of Sweden and Belgium. This means that in most IVF clinics, the decision for 
the number of embryos transferred is established through a form of shared decision-
making involving both IVF patients and professionals. If we would want to reduce the 
multiple pregnancy rate in the future, it is essential to identify why the decision to 
perform eSET is so difficult. 
Previous studies concerning the decision-making process focused mainly on the 
couples’ desire for twins or their lack of knowledge on twin-related complications.16-22 
However, these studies used quantitative questionnaires and did not explore all 
aspects of the decision. Furthermore, it is essential to realize that professionals are 
also involved in taking the decision. To obtain true insight in this decision-making 
process it is necessary to perform an exploratory investigation at both the level of IVF 
patients and professionals. 
Therefore, the aim of this study is to explore factors related to the decision for the 
number of embryos transferred, in particular factors preventing the use of eSET, at the 
level of both IVF patients and professionals. 
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Materials and Methods
Study design
We performed explorative semi-structured interviews among Dutch IVF professionals 
and patients who had just undergone IVF or were on the waiting list for IVF. To develop 
an interview guide for both IVF professionals and patients, we used two theoretical 
models for identification of influencing factors.23,24 These models had four similar 
domains: characteristics of the innovation itself (e.g. cost-effectiveness), professionals’ 
characteristics (e.g. attitude towards eSET), patients’ characteristics (e.g. desire for 
twins) and characteristics of the context in which the innovation has to be applied (e.g. 
legislation). 
Setting
In the Netherlands, IVF and ICSI are performed in 13 licensed hospitals: eight university 
hospitals, four general hospitals and one private clinic. Hospitals without a licence can 
initiate and monitor the stimulation phase and refer to a licensed hospital for both 
oocyte retrieval and embryo transfer (satellite clinics) or for embryo transfer alone 
(transport clinics). The costs of the first three fresh IVF or ICSI cycles are currently 
reimbursed by the national healthcare system, but only if no more than two embryos 
are transferred. The choice for either one or two embryos is taken by both the couple 
and the professional and is discussed at the hospital where the treatment is initiated. 
Interviews among IVF professionals
We performed the interviews at seven locations: three university centres, two 
general hospitals, one transport clinic and one satellite clinic. At each location, 
three professionals at different levels of expertise and with different roles in IVF were 
asked to participate by the local head of department: a consultant gynaecologist, 
a fertility doctor and an IVF nurse. The centres were randomly selected by a senior 
gynaecologist of our department. In total, 20 professionals (one clinic did not have IVF 
nurses) participated. We interviewed the IVF professionals individually, thus allowing 
them to discuss the issue in the absence of their direct colleagues. The structure of 
all interviews was identical; we started with explorative questions for possible factors 
related to the choice for eSET or DET. Subsequently, we asked questions about all 
factors potentially related to eSET use, suggested by the models. The interviews took 
∼30 min and all were audio taped and transcribed. 
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Patient focus-group interviews
We performed two focus-group interviews among patients of our own university IVF 
centre who were non-pregnant, living within 30 km of our centre and had no recent 
physical or psychosocial problems. We invited 28 couples (56 patients) on the IVF 
waiting list and 22 couples (44 patients) who had already experienced one or more 
IVF cycles. A group setting was chosen because we expected that this might lead 
to the identification of more relevant factors related to the choice for eSET or DET. 
Furthermore, previous research reported that patients preferred a group setting and 
demonstrated no differences in results obtained from individual and group interviews.25 
In our study, both interviews were moderated by an independent gynaecologist not 
involved in IVF. The structure of the focus-group interviews was similar to the interviews 
at the professional level: after asking explorative questions, we specifically asked the 
participants to reflect on potential factors influencing the choice for eSET or DET. The 
interviews took ∼90 min each and were also audio taped and transcribed. 
Analysis
All interviews were independently analysed by two sets of two researchers (A.M.P., 
L.J. and A.M.P., W.L.D.M.N.). The factors identified were scored according to the two 
models23,24 and placed in the appropriate domains. Factors identified, but not present in 
the models, were added. The two sets of scores were compared and any discrepancies 
were discussed until consensus was achieved. 
 
Results
Our participants described a variety of factors which potentially influenced the choice 
for eSET or DET, in all four domains of the theoretical models. We identified 37 factors 
at the level of IVF professionals (Table I) and 26 among the IVF patients (Table II). 
We summarized in more detail the factors that were mentioned by at least two-thirds 
of the professionals or patients. We present the factors according to the four domains 
of the theoretical models: characteristics of eSET (Domain 1), characteristics of the 
professionals (Domain 2), characteristics of the patients (Domain 3) and  characteristics 
of the context (Domain 4). For greater clarity, we will describe all found factors as 
potential barriers for eSET. Quotes are taken verbatim from the transcripts of the 
interviews and are presented in separate sections with italic text. 
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Factors related to the choice for eSET or DET according to IVF professionals 
(table I)
Because one professional was on sick leave, we interviewed 19 IVF professionals 
(response rate 95%). Characteristics of the professionals are shown in Table III.  
The following factors were suggested by two-thirds of the professionals. 
Domain 1: Characteristics of eSET itself
Uncertainty about eSET technique
Every respondent mentioned the potential disadvantages of performing eSET: a lower 
pregnancy rate per cycle and the potential burden of necessary extra cycles to achieve 
pregnancy. 
‘...and because of this decrease [in pregnancy rate] per cycle, you give people an extra 
burden. Because every treatment is an additional burden’. 
Lack of prognostic models for eSET
Additional knowledge on prognostic factors is felt to be necessary before eSET can 
be implemented. The professionals described their difficulty in discriminating between 
couples eligible for eSET and couples with a less favourable profile. They told us that 
they often choose the ‘safe option’; DET instead of eSET. 
‘I think that eSET use will increase in the future, but I hope that we will know even better 
in which patient categories and to what extent we can apply this’. 
Why don’t we perform eSET? A qualitative study among IVF patients and professionals
Gender  Gynaecologists  Fertility doctors  IVF nurses  
Men 4 2 0
Women 3 4 6
Median age (years) 43 43 44 
[range] [39-63] [28-45] [35-47]
Median years of expertise 7 13 8
[range] [2-26] [3-16] [5-11]
Median number of colleagues     2 4 5
[range] [1-4] [0-6] [2-7]
Table III  Characteristics of the participating IVF professionals
IVF = in vitro fertilisation
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Inferior cryopreservation success rates
All professionals mentioned the necessity for improvement of cryopreservation success 
rates before the use of eSET can be increased. Without this improvement, they feel that 
they are wasting embryos and that the burden of an IVF cycle is too high to transfer 
only one embryo. 
‘They [Finland] freeze more frequently than we do and they freeze one by one, which 
we don’t ... That has to reach a higher level in this country before you can implement 
something like that[eSET]’. 
Domain 2: Characteristics of the professionals
Negative attitude towards eSET
Not all professionals wanted to prevent twins in all cases; not everyone defined twins 
as a complication of IVF. 
‘In the Netherlands, we focus too much on the pregnancy itself, and you should actually 
focus on when the family is complete. Most people don’t want only one child. And if you 
take away their chance to form a complete family, by always transferring just one embryo 
... I think that this is not always the right thing to do’. 
‘I think a twin is not always a drama, for some people it is a blessing!’ 
Necessity for sufficient communicating skills
To make a thorough decision, couples must comprehend the complex facts 
concerning eSET. A good explanation and clear information about the chances for a 
(twin) pregnancy and the consequences of eSET and DET ensures that patients are 
better prepared to make a good decision. Our participants stated that clinicians who 
are unable to provide thorough and accurate information about eSET and DET will 
adversely influence eSET implementation. Moreover, whether information is provided 
objectively or through directive counselling may also impact on the use of eSET. 
‘I think that at the moment you inform your patients in a better way and you can bring it 
all into perspective, it would be favourable for the patient, because they would feel more 
secure, as in: ‘it will be alright, I’m in good hands’. 
‘I think, the more directive you counsel, the easier your patients will be compliant’. 
Lack of negative experience with twins
If a professional has experienced a negative incident with twin pregnancies, this could 
strongly influence the use of eSET. Our participants suggested that professionals 
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working only with subfertile couples, and not with obstetrical complications, would 
be less inclined to regard twins as a complication instead of a success. Furthermore, 
personal experiences with multiple pregnancies, either positive or negative could also 
have impact. 
‘Look what happens [in the hospital] at night time! One immature twin after the other, 
always a mess with twins on the ward’.
‘I myself am the mother of a triplet. Patients don’t know that about me, and that is not up 
for discussion, but that also determines what you say of course’. 
Professional level
The participants suggested that the level of profession may also influence the attitude 
towards eSET. A gynaecologist has more obstetric experience than an IVF doctor or 
nurse and might therefore be more aware of the disadvantages of twin pregnancies. 
Consequently, if an IVF cycle is mostly monitored by IVF doctors and nurses, as is 
often the case in the Netherlands, this could impede the eSET use. 
Maybe a gynaecologist is more aware of the misery you can have with a twin, and is 
also more confronted with the large amount of twin pregnancies, compared to the IVF 
doctors and nurses. 
Domain 3: Characteristics of the patient
Lack of knowledge of patients about essential eSET aspects (as perceived by the 
professionals)
Patients’ lack of knowledge about essential aspects of eSET was often mentioned as a 
factor influencing eSET use. According to the professionals, patients have insufficient 
knowledge about twin-related risks and pregnancy rates after eSET to make an 
objective decision. They may have problems in interpreting information provided by 
professionals. A better understanding of essential information could facilitate the 
implementation of eSET. 
‘They don’t always have the knowledge to take the right decision’. 
‘...because patients just cannot make an objective decision about this. Instinctively, 
two gives a higher chance than this in fact does. They just think: two is possible, so 
they want two... They don’t know the risks related to that and they cannot judge this for 
themselves I think’. 
Why don’t we perform eSET? A qualitative study among IVF patients and professionals
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Domain 4: Characteristics of the context
Impeding reimbursement system
Many respondents were dissatisfied with the organization of the Dutch reimbursement 
system and mentioned it as a barrier for the implementation of eSET. The professionals 
felt that adjustment of the system, towards the reimbursement of more IVF cycles, will 
help to implement eSET. Many participants mentioned the Belgian system, where the 
costs of six cycles are reimbursed, and the number of embryos transferred varies with 
age and number of cycles, as an ideal way to implement eSET. 
‘Health Insurance companies reimburse differently. The clinician will act according to this’. 
‘eSET is a good method for the prevention of a twin pregnancy, but it shouldn’t be 
applied on a large scale until the moment that more cycles are reimbursed’. 
Variation between hospitals
Professionals often mentioned variation between clinics in opinions about eSET 
and twins in the Netherlands and felt that the lack of consensus might hinder the 
 implementation of eSET. 
‘I talk to a lot of colleagues around the country, and I know that some clinicians care a 
lot more about the prevention of twins than others’. 
Absence of protocol
A protocol that defines when to perform eSET could improve its implementation. If the 
decision is made according to clinical parameters only, clearly described in a protocol, 
this rules out other options for the couple or professional. Furthermore, even if such a 
protocol merely suggests certain options, it will enhance eSET implementation. 
‘The protocol is something to hold on to’. 
‘Look, it is easier to hide behind something [protocol]’. 
Factors related to the choice for eSET or DET according to patients (table II)
For the first focus-group eight couples (n = 14, two women participated without their 
partner) from the waiting list for IVF consented to participate, giving a response rate 
of 29%. The second focus-group session consisted of three couples (n = 6) with 
IVF experience (response rate 14%). Characteristics of the participating patients are 
outlined in Table IV. The factors discussed by at least two-thirds of the patients are 
located in three of the four domains of the theoretical models: characteristics of eSET, 
the patients themselves and the context of the IVF treatment. 
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Domain 1: Characteristics of eSET itself
Uncertainty about eSET technique
For many participants, it was clear that the use of eSET also had disadvantages. 
The decision between eSET and DET was described as a difficult balance between 
optimal chance of pregnancy and the lowest possible risk of complications. 
‘I think having two babies at once would be an advantage, however with twins you have 
the medical risks involved’. 
Domain 3: Characteristics of the patients themselves
Lack of knowledge of patients about essential eSET aspects
Patients felt themselves inadequate to make a decision about the number of embryos 
transferred. Even patients with IVF experience were not satisfied with their level of 
knowledge. Lack of, or inadequate, information inhibits the use of eSET. 
‘We don’t think that we have received enough general information to make the decision 
on the number of embryos transferred’. 
‘We did not receive any information on twin risks, no details, nothing. At our first outpatient 
visit this was not discussed’. 
Liberty of choice
Our participants mentioned their need to be part of the decision-making process for 
the number of embryos transferred. It is difficult to say if this freedom of choice actually 
impedes or facilitates the use of eSET. 
Why don’t we perform eSET? A qualitative study among IVF patients and professionals
Gender  Patients on Patients with 
 IVF waiting list IVF experience  
Men 6 3
Women 8 3
Median age in years 34 34 
[range] [26-68] [30-40]
Median duration of subfertility in years 2 3
[range] [1-6] [3-4]
Table IV  Characteristics of the participating patients
IVF = in vitro fertilisation
71
‘I will make that decision myself. This should be done by the patient, not the doctor’. 
‘The couple eventually makes the decision for eSET or DET, but of course after consulting 
the professional’. 
Focus only on chance for pregnancy
For subfertile couples, becoming pregnant is the main priority with the chance of twins 
seen as of secondary importance. 
‘When I compare it with the lottery two tickets gives more chance for success compared 
to only one’. 
‘It is important to feel that you have tried everything to become pregnant’. 
Anxiety for experiences of the first treatment cycle
For patients it is very important how they will cope with the experience of the first IVF 
cycle. If this experience turns out to be negative, they might decide to perform DET 
instead of eSET, since an eSET regime might require more cycles. 
‘You can read all about it, but you will not know how you will react on the hormones, 
how you will cope with the daily injections and how you will experience the time period 
before and after the oocyte aspiration’. 
‘If the first attempt is very tough, I do not want to endure this again. In that case I really 
want to have two embryos transferred’. 
Domain 4: Characteristics of the context
Impeding reimbursement system
Reimbursement of the costs of IVF has impact on the choice for the number of embryos 
transferred only when the patient experiences direct negative effects of the rules. 
Patients with sufficient insurance policy have no problem with higher medical costs. 
However, lack of reimbursement may hinder eSET use, because patients will then aim 
for the maximal chance for pregnancy. 
‘I won’t think about medical costs. I have a good insurance policy. They will pay for my 
treatment’. 
‘Aren’t insurances supposed to take care of this? There is a double standard: they do 
not reimburse our IVF, but they do pay for the multiple pregnancies after an IVF treatment 
with many embryos abroad’. 
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Discussion
 
This study describes the numerous factors that influence Dutch IVF professionals and 
patients regarding the use of eSET. We identified three important potential barriers for 
eSET that both patients and professionals find important. First, there is uncertainty 
about the advantages of performing eSET. It prevents twin pregnancies10, but may also 
mean a lower success rate per cycle.8,12 Therefore, the choice for eSET is not easily 
taken. Second, couples undergoing IVF often have insufficient knowledge to make an 
informed decision for eSET or DET. They may not acknowledge the twin-related risks or 
decide for DET simply because they think this could double their chances of pregnancy. 
Previous research demonstrated that, if patients understood the complications 
associated with twins, this might result in a change of attitude in favour of eSET.20,26 
Moreover, it is vital that patients realize that if they accept possible extra cycles, the 
pregnancy rates for eSET and DET are similar.8,11 Third, eSET implementation requires 
a cost reimbursement system that favours eSET and not DET. If no reimbursement 
system exists or when the cost of only a fixed number of cycles are reimbursed, this 
may act as a financial incentive for DET.27 
During the interviews, the professionals stated their feelings that eSET is not ready 
for full implementation. They suggest that some clinical aspects of eSET need to be 
improved before it can be commonly used in clinical practice. An improved prognostic 
model to enable professionals to select appropriate couples for eSET would be 
helpful and may minimize the lower success rate reported with eSET in an unselected 
population.12 New prediction models have recently been published28,29 but none of them 
are as yet translated to daily practice. The same situation applies to embryo selection. 
Better identification of the most suitable embryos will allow professionals to identify the 
couples with good prospects for pregnancy who are therefore suitable for eSET. New 
embryo selection methods have been suggested30,31, but their value remains uncertain 
for other settings, because they have not been broadly adapted. Another important 
factor is cryopreservation. The Dutch professionals are not content with the local 
success rates with frozen-thawed embryos and without exception mention the much 
better results in other European countries.11,32 Therefore, it will be difficult to implement 
eSET in the Netherlands without improvements in couple and embryo selection and 
without improvement of cryopreservation success rates. 
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Noteworthy is that not all professionals felt the need to prevent twin pregnancies. This is 
in agreement with previous publications13,14,33,34, although a recent study has presented 
a different view.35 Since the professional has an important say in the decision-making 
process, a doctor who does not feel the need for twin prevention will probably be 
reserved in advising eSET. This study cannot explain why some professionals do not 
regard twins as a complication of IVF. However, it is important to consider that for 
some couples with a less favourable prognosis, for instance where the female has an 
elevated level of follicle-stimulating hormone, a multiple pregnancy should probably 
be regarded as a success instead of a complication. More research on this topic is 
necessary. 
Our exploration among couples revealed that most couples did not really desire twins 
but focused on their chance to become pregnant. Although most patients agreed that 
a healthy singleton is the goal of IVF, they would accept a twin pregnancy if that was 
necessary to become pregnant. This finding may offer an opportunity for the design 
of an intervention to increase the use of eSET, especially if couples are informed that 
eSET combined with cryopreserved embryos equals the success of DET.11 Our finding 
is in contrast with other studies reporting a high desire for twins17-19,21,22 This discrepancy 
may be explained by our qualitative approach. During our interviews, the participants 
were able to explain that they only desire a twin in specific situations. Possibly the 
participants of the previous quantitative questionnaire studies lacked this opportunity. 
Patients also reported that they want to decide for the number of embryos transferred 
after experiencing the hormonal ovarian stimulation and oocyte aspiration. It is difficult 
to predict what the effect on eSET use would be, if this was allowed. 
This study was designed to explore influencing factors regarding the choice for the 
number of embryos transferred with a qualitative approach. It enabled us to explore 
all potential factors related to the choice for eSET or DET, which is very difficult if not 
impossible with a quantitative approach.36 Our approach might enable clinicians in the 
field of IVF to select the relevant factors applicable to their own setting and use them 
to improve the use of eSET. 
There are obviously some limitations to our study. First, interpretation of interviews 
is vulnerable to bias. For this reason, we decided to analyse all transcriptions on the 
basis of two theoretical models and with two independent researchers who took no 
part in the IVF procedure. Second, it is impossible to estimate the impact of each factor 
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upon the choice between eSET and DET. This would require quantitative confirmation 
and assessment of the magnitude for the factors. Such confirmation would also 
enable the effects of different cultural, religious or locational settings to be analysed. 
Third, couples had a low participation rate which is difficult to explain. However, this is 
unlikely to have adversely affected the factors identified. A last limitation of our study 
is the Dutch setting. Other countries operate in a different context (e.g. reimbursement 
system) and Dutch IVF professionals may have a different opinion about eSET use, 
compared with others. However, many of the factors identified are not specifically 
related to the Dutch setting, so that the results of this study may be relevant to other 
countries. Therefore, despite its limitations, we believe our work provides necessary 
insight into the complex process behind the decision for eSET or DET. 
In conclusion, our study identified several relevant factors influencing the decision-
making process concerning the number of embryos transferred, at both the level of 
the IVF patients and professionals. However, to estimate the impact of the identified 
factors, a quantitative confirmation and assessment of the magnitude of the effect is 
necessary. 
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Abstract
 
BACKGROUND: After initial years of improvement, the multiple pregnancy rate after 
in vitro fertilization (IVF) in Europe now remains stable at 23% with single embryo 
transfer (SET) constituting 19% of all IVF cycles. Although elective SET prevents 
multiple pregnancies after IVF, couples and professionals apparently often decide to 
transfer more embryos. Previous qualitative research has identified factors that impede 
the use of elective SET. The aim of this study was to quantify those barriers among 
IVF professionals and to identify predictors of professionals’ willingness to perform 
elective SET. 
METHODS: A national survey among all Dutch IVF professionals quantified the 
barriers suggested by a previous qualitative study and assessed characteristics of 
the professionals and clinics. Multivariate analysis identified predictors related to the 
willingness of IVF professionals to perform elective SET. 
RESULTS: In total, 107 professionals participated. The most frequently mentioned 
barriers to elective SET use were suboptimal success rates associated with 
 cryopreservation (96%), not seeing twin pregnancies as a complication (79%) and lack 
of a SET protocol (78%). Two variables seem to predict the professionals’ willingness 
to perform elective SET: university hospital of the initial fertility training (P< 0.01) and 
high scores of perceived barriers, e.g. professionals’ attitudes and skills (P < 0.01). 
The explained variance of these two variables was 25%. 
CONCLUSIONS: This study has identified the main barriers to elective SET use and 
predictors for willingness of professionals to perform elective SET. This insight into the 
decision-making process could be critical in terms of increasing the use of elective SET.
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Introduction
 
Multiple pregnancies are associated with higher rates of mortality and morbidity 
for both mother and child than singleton pregnancies 1-3, and the costs of multiple 
pregnancies are also higher.4,5 Elective single embryo transfer (eSET) prevents multiple 
pregnancies after in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI).6-9 
However, the use of eSET in clinical practice may also be disadvantageous. Elective 
single embryo transfer could result in a lower pregnancy rate per cycle7,9, especially in 
an unselected population.10 The difficult balance between maintaining an acceptable 
pregnancy rate and the prevention of multiple pregnancies is probably the reason 
why the  implementation of eSET in clinical practice has not been impressive so far. 
After earlier years of improvement, the multiple pregnancy rate for IVF in Europe 
now remains stable at 23%, while the proportion of single embryo transfers is slowly 
approaching 19%.11 The question remains why eSET is not performed more often, 
especially for couples with good prospects of becoming pregnant. 
With the exception of those for Belgium and Sweden, no national SET legislation 
systems or compulsory SET protocols exist.12,13 This means that in most European 
IVF clinics the decision for the number of embryos transferred is taken by both the 
professional and the couple in a process of shared decision-making. To find out why it 
is so difficult to perform eSET, we need to obtain more insight into this decision-making 
process and the factors that influence the number of embryos transferred. 
In a recent qualitative study among a selected group of IVF professionals, we identified 
such influential factors, which were distributed over four domains.14 The four domains 
consisted of features of the eSET technique (e.g. cost-effectiveness), the professionals 
(e.g. attitude), the couples (e.g. financial situation) and the context in which eSET was 
applied (e.g. reimbursement system). To confirm these findings in a large group of IVF 
professionals, we conducted a quantitative study in two ways. First, we determined 
which of the factors found in our previous qualitative study were most frequently 
perceived as barriers to eSET use. Second, to interpret these perceived barriers 
within the whole spectrum of the IVF treatment, we also measured characteristics of 
the professionals and their clinics. With this approach we determined which of the 
barriers and characteristics predicted the professionals’ willingness to perform eSET. 
These predictors provide necessary insight into the complex decision for the number 
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of embryos transferred and could be the first step for developing a strategy to improve 
eSET use. 
Thus, the aims of this study were to quantify the barriers perceived by IVF professionals 
to perform eSET and to determine what variables predict the professional’s willingness 
to perform eSET. 
Methods
 
Setting
In the Netherlands, IVF and ICSI are performed in 13 licensed hospitals: eight university 
hospitals, four general hospitals and one private clinic. Professionals in a hospital 
without a licence can start up and monitor the stimulation phase and refer to a licensed 
hospital for the oocyte retrieval and/or embryo transfer. Consultant gynaecologists and 
fertility doctors carry out IVF. Fertility doctors are not consultant gynaecologists, but 
have received IVF training at their local departments and work under the supervision of 
gynaecologists. The national healthcare system currently reimburses the costs of the 
first three fresh IVF or ICSI cycles, but only if maximally two embryos are transferred. 
Any transfers of cryopreserved embryos are included in the costs of the three fresh 
cycles. The decision for either one or two embryos is taken by both the couple and the 
professional in a process of shared decision-making. 
Study population
We approached 65 consultant gynaecologists specialized in fertility and who are 
currently registered with the Dutch Society of Obstetrics and Gynaecology (NVOG). 
Hence we were able to invite all the consultant gynaecologists in the Netherlands 
because their NVOG membership is obligatory. Furthermore, we obtained the e-mail 
addresses of all fertility doctors who are members of the Dutch Society of Fertility 
Doctors (VVF). Since not all fertility doctors are registered with the VVF, we also 
contacted every hospital that performs IVF to find out about any other fertility doctors. 
This resulted in a total of 99 fertility doctors whom we invited to participate. In total, we 
invited 164 Dutch IVF professionals to complete our questionnaire. 
Survey development and deployment
The questionnaire contained two parts. The first part consisted of 35 Likert scale items 
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concerning the barriers to eSET use that were identified in our previous qualitative 
study.14 The five point Likert scale items ranged from total disagreement to total 
agreement with a particular factor as a barrier for eSET use. The second part contained 
14 questions about characteristics of the professionals and their clinical settings that 
potentially influence the decision for eSET or double-embryo transfer (DET). Examples 
of the characteristics are age, gender, and the type of hospital in which the professional 
worked. We measured the professionals’ willingness to perform eSET by asking them: 
‘For what percentage of couples, who have at least two embryos available for transfer, 
would you recommend eSET in the next three months?’ 
We approached all doctors by e-mail in December 2007 and invited them to fill in 
the Web-based questionnaire. Two reminders were sent in a period of 10 weeks. 
This questionnaire did not accept unanswered items, so that no data were missing 
from the database. If participants wished to explain their answers in detail, they could 
do so at the end of the questionnaire. 
Statistical analysis
To quantify the barriers to eSET as IVF professionals perceived them, we classified 
the Likert scale responses as 1 = disagree, 2 = neutral or 3 = agree and calculated 
the percentage of professionals who agreed that an item is a barrier for eSET use. We 
described the frequencies of eSET willingness and characteristics of the participants. 
We used multivariate analysis to identify possible predictors of the willingness of IVF 
professionals to perform eSET. We calculated Cronbach’s α for each of the four barrier 
domains to assess their reliability. It was necessary to perform a factor analysis to 
select the reliable items for the domain of the professionals and the context, because 
the initial Cronbach’s α values were <0.5. At least six items in each domain persisted 
after the factor analysis, and the resulting Cronbach’s α values were 0.61, 0.62, 0.79 
and 0.61 for the domains of the eSET technique, the professionals, the couples and 
the context, respectively. We calculated sum scores for the persisting items in each 
domain by adding up the scores of all ‘disagree’, ‘neutral’ and ‘agree’ categories. 
The characteristics of the professionals and the clinical settings, as well as the sum 
scores of the four barrier domains, were tested for univariate relationship with the eSET 
willingness in order to select the items for the multivariate analysis. The relationship 
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between the eSET willingness (a percentage and therefore a continuous variable) 
and the dichotomous characteristics was analysed with the Mann–Whitney U test, the 
relationship between categorical characteristics and eSET willingness was determined 
with a Kruskal–Wallis test and the correlation between continuous characteristics 
and the eSET willingness was analysed with Pearson’s correlation. Variables with 
P ≤ 0.15 were found to be eligible for multivariate regression analysis. In the multivariate 
analysis the eSET willingness was the continuous dependent variable. A backward 
selection method was applied, and factors with P < 0.05 were considered significant. 
Statistical Products Services and Solutions (SPSS), version 14.0.1, Chicago, IL, was 
used for the statistical analyses. 
 
Results
Of the 164 professionals approached, 107 participated; 46 consultant gynaecologists 
and 61 fertility doctors, with response rates of 71 and 61%, respectively. Table I shows 
the characteristics of the participants. The mean age, proportion of male professionals 
and years of experience were greater in the group of consultant gynaecologists (the 
supervisors) than in the group of fertility doctors. These differences reflect the standard 
structure of Dutch IVF teams with fertility doctors under supervision of consultant 
 gynaecologists. 
  
Perceived barriers for eSET use among IVF professionals
Table II shows the proportion of professionals who perceived specific barriers to eSET 
use. Barriers with high scores in the domain of the eSET technique were: suboptimal 
success rates associated with cryopreservation (96%), uncertainty about the eSET 
pregnancy rate per cycle (30%) and the cost-effectiveness of eSET use (28%). In the 
domain of the professionals, the main barriers were: not perceiving a twin pregnancy as 
a complication (79%), doubts about the consequences of full implementation of eSET 
in clinical practice (42%) and professionals feeling more responsible for the couples’ 
wish for pregnancy than for the extra risk to the baby’s health (23%). The couple’s 
reluctance to accept eSET when they had undergone DET before (44%), their desire for 
twins (36%), their freedom of choice to decide the number of embryos transferred (30%) 
and their lack of knowledge about eSET success rates and twin-related complications 
(29%) were the most important barriers in the domain of the couples, according to the 
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professionals. Within the domain of the context of the IVF treatment, the absence of a 
protocol (78%), the head of the IVF department not encouraging eSET (66%), lack of 
eSET legislation (66%) and the Dutch system of reimbursement (51%) were important 
perceived barriers to eSET use. 
 
Table II also shows that some potential barriers identified in our previous qualitative 
study14 were not considered important. In the domain of the eSET technique itself, 
lack of objective eSET results (0%), lack of opportunity to observe others performing 
eSET (7%) and lack of a scientific basis for eSET use (8%) all scored low as perceived 
barriers. Within the domain of the professionals, time investment for eSET (0%), difficulty 
of changing routines (4%) and lack of knowledge about or motivation for eSET (7%) 
were not seen as important barriers. National differences about eSET use (8%) or the 
potential publication of poor results (8%) were not important as barriers in the domain 
of the context of the IVF treatment. 
Predictors of professionals’ willingness to perform eSET
The willingness of the 107 IVF professionals to perform eSET ranged from 0 to 100% 
with a median value of 70%. Table III shows the variables selected for the multivariate 
analysis to identify predictors of professionals’ eSET willingness. Among the 
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Gender  Gynaecologists Fertility doctors 
Number of professionals  46 (43%) 61 (57%)
Gender 
Male 76% 8%
Age in years
Mean (range) 49 (43-62) 38 (24-57)
Years of experience 
Mean (range) 16 (1-35) 8 (0.5-21)
Type of IVF clinic
University hospital  18 (39%) 33 (54%)
Clinic with IVF licence  4 (9%) 11 (18%)
Clinic without IVF licence  24 (52%) 17 (28%)
Table I  Characteristics of the participating professionals (n= 107)
IVF = in vitro fertilisation
88
Perceived barriers to eSET among IVF professionals: a national survey
 
Domain of eSET technique
Suboptimal success rates associated with
cryopreservation
Uncertainty about eSET technique (lower 
pregnancy rate per cycle/more cycles
necessary with eSET)
Low cost-effectiveness of eSET
Lack of prognostic factors and models to
identify eSET candidates
Lack of scientific basis for eSET use
Lack of opportunities to observe eSET 
results in other clinics
Lack of objective results 
Domain of professionals
Not perceiving twin pregnancies as a
complication of IVF
Doubts about consequences of full 
implementation of eSET
Feeling more responsible for the couples’ 
wish for pregnancy despite the risks for 
the babies
Poor doctor–patient relationship
Location of fertility training
Lack of communication skills 
Lack of experience with complications of 
twins
Lack of knowledge about and motivation 
for eSET
Difficulties in changing routines
Lack of time to perform eSET
Domain of patients
Unwillingness of patients to consider eSET
after they have undergone DET before
Patients’ desire for twins
Patients’ freedom of choice
Percentage of IVF professionals that
perceive this as a barrier  
96
30
28
17
8
7
0
Percentage of IVF professionals
79
42
23
21
16
14
13
7
4
0
Percentage of IVF professionals
44
36
30
Table II  Barriers impeding the use of elective single embryo transfer in  
clinical practice according to the four barrier domains
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professionals’ characteristics, only previous positive experiences with twins (P = 0.03), 
the university hospital of initial fertility training (P = 0.06) and their opinions about the 
minimum pregnancy rate that must be maintained while preventing twin pregnancies 
(P = 0.08) were eligible for multivariate analysis. Among the characteristics of the 
clinical setting, only the presence of a protocol (P = 0.06) and the number of IVF cycles 
performed annually (P = 0.09) were included in the multivariate model. With respect 
to the sum scores of the four domains of barriers, the domain of the eSET technique 
(P = 0.02) and the domain of professionals (P < 0.01) were used for multivariate 
analysis. 
Within this multivariate analysis, two of the seven variables from the univariate analyses 
seemed to predict eSET willingness of the IVF professionals. First, the university hospital 
of initial fertility training of the professionals was of significant importance (P < 0.01); 
it influenced a professional’s willingness to perform eSET. Second, the sum score of 
Chapter 5
5
Lack of patients’ knowledge about 
twin-related risks
Lack of patients’ sense of responsibility 
for consequences of eSET
Patients’ strict religion
Poor financial situation of patients
Domain of context of IVF treatment
Absence of eSET protocol
Lack of legislation about eSET
Lack of leadership stimulating eSET
Impediments of Dutch reimbursement system
Impeding mentality of the society
Media coverage of IVF and twins
Lack of continuity of care due to eSET use
Type of practice (university vs general
hospital)
Competition between hospitals
Publication of poor performance
Differences in professional opinions about
eSET nationwide
29
18
13
10
Percentage of IVF professionals
78
66
66
51
33
29
25
20
16
  8
  8
IVF = in vitro fertilisation; eSET = elective Single Embryo Transfer; 
DET = Double Embryo Transfer
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the barriers in the domain of the professionals significantly predicted the willingness of 
professionals to use eSET (P < 0.01). A higher sum score, which implies more barriers 
perceived by the professional, makes it less likely that a professional will perform 
eSET. If, for instance, a professional believes that prevention of twin pregnancies is 
unnecessary or considers cryopreservation success rates too low, then he or she will 
tend to use eSET less often than professionals who perceive fewer barriers in daily 
practice. The explained variance of the two variables was 25%. 
Perceived barriers to eSET among IVF professionals: a national survey
 P value 
Personal characteristics of the professionals
Previous positive experiences with multiple pregnancies  0.03*
University hospital of initial fertility training  0.06*
Opinion about minimum IVF success rate with prevention of twin pregnancies  0.08*
Gender 0.59
Years of experience 0.59
Percentage of obstetrical duties  0.59
Type of professional (gynaecologists vs fertility doctors) 0.68
Presence of multiple pregnancy in direct family of professional 0.81
Age 0.99
Characteristics of clinical setting 
Presence of protocol for number of embryos to be  transferred  0.06*
Number of IVF cycles/year   0.09*
Number of SET/DET counselling sessions per week 0.45
Type of IVF clinic 0.47
Type of professional discussing the number of embryos transferred 0.93
Sum scores of domains of experienced barriers of professionals (Table II)
Domain of eSET technique  0.02*
Domain of IVF professional  <0.01*
Domain of patients 0.77
Domain of context of IVF treatment 0.48
*Variables with p≤ 0.15 were included in multivariate analysis 
IVF = in vitro fertilisation; eSET = elective Single Embryo Transfer; 
DET = Double Embryo Transfer
Table III  Univariate relationship of the professional and hospital  
characteristics and sum scores of barriers to willingness to 
perform eSET: selection of variables for multivariate analysis
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Discussion
 
The results of our national survey show that most Dutch IVF professionals perceive 
different barriers for eSET use in clinical practice in the domains of the eSET technique, 
the professionals, the couples and the context of IVF treatment. Furthermore, we have 
shown that the university hospital of initial fertility training and barriers perceived in the 
domain of the IVF professionals are predictors of the willingness of IVF professionals 
to perform eSET. The barriers to eSET use and the predictors of eSET willingness 
provide necessary insight into the decision-making process for the number of embryos 
transferred. 
In the domain of the eSET technique, our survey demonstrates that 96% of the 
participating Dutch professionals felt that suboptimal success rates associated with 
cryopreservation impede the use of eSET. Although previous research has shown that 
the results of cryopreservation in other countries are good9,15, apparently a majority 
of Dutch professionals agree that improvement of the current Dutch  cryopreservation 
results would stimulate the use of eSET. Furthermore, lower pregnancy rates 
per cycle and low cost-effectiveness created uncertainty about eSET and its full 
implementation. The reports of eSET success rates per cycle from earlier studies7-10 
and eSET cost-effectiveness4,5 were obviously not enough to convince professionals. 
In the professionals’ domain, high barrier scores mainly reflected the attitude of the 
professionals toward twin pregnancies as a complication, the consequences of eSET 
use and the obligation to fulfil the couple’s wish for pregnancy despite the risks for the 
babies. Previous studies report comparable results.16-19 However, a recent study among 
Nordic professionals revealed a more positive view, which suggests that a change in 
professional attitude is possible.20 In the domain of the patients, professionals observed 
a desire of the couples for twins, which may partially stem from their earlier experiences 
with DET.21 The couples may also have lacked knowledge about eSET success rates 
and twin-related complications.22,23 Our previous qualitative study among IVF couples 
revealed that this desire for twins was not so much a desire for two babies, but more 
a wish to maximize the chances of becoming pregnant.14 In the domain of the context 
of IVF treatment, we identified barriers at two levels. At the level of the local clinic, 
the lack of a protocol or absence of a head of the IVF department who favours eSET 
impeded its use. At the national level, professionals perceived lack of legislation and 
the current Dutch reimbursement system as barriers. If eSET legislation or compulsory 
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SET protocols exists, the opportunity for DET is no longer an option and this will have 
significant impact on eSET implementation.12,13
If adapted to the specific local clinical setting, the perceived barriers for eSET identified 
in this study could be the first step for the development of a strategy to improve the 
implementation of eSET, especially if it took into account the predictors for eSET 
willingness of the professionals. Such a strategy could help to achieve optimal eSET 
use, particularly since Dutch IVF professionals seem to be open to suggestions to 
reduce the multiple pregnancy rate with eSET. Our study shows that IVF professionals 
are motivated to use eSET, feel that they are informed about eSET developments and 
results and do not worry about time investment or changing their routine. Examples of 
strategies to increase the use of eSET could include: improvement of cryopreservation 
results and a focus on twin-related risks and twin prevention for IVF professionals. 
For patients, we could consider improving their knowledge of the essential aspects of 
eSET and twin risks. Previous research has shown that this could result in a change of 
attitude in favour of eSET.24,25
We have shown that the university hospital where the professional receives initial fertility 
training and the perceived barriers in the domain of the professionals are significantly 
related to willingness of professionals to perform eSET. The explained variance of 
these two variables is 25%, which implies that a large proportion of a professional’s 
willingness to use eSET is influenced by these two characteristics. It seems that 
focusing on changing the training of professionals and their attitudes towards eSET 
could significantly improve their willingness to perform eSET. 
One strong point of our study is that the questionnaire was based on the factors 
identified by our previous qualitative study.14 This method assures that the survey is 
not merely testing the authors’ personal hypothesis, but truly represents the complete 
spectrum of the eSET implementation problem. Such methodology might be a good 
example for future care evaluations. Another strong point is that we measured the eSET 
willingness within the complete context of the decision-making process. We combined 
the perceived barriers in a model with characteristics of the professional and the clinic 
so that we could determine which factors predict the willingness to perform eSET. Yet 
another strong point is the national setting of our study, with participation rates of 71% 
for the consultant gynaecologists and 61% for the fertility doctors. 
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However, this national setting could also be seen as a limitation. A different context 
(e.g. presence of legislation) exists in other countries, and the Dutch IVF professionals 
may perceive different barriers from those perceived elsewhere. Nonetheless, most 
of the barriers are probably not specifically related to the Dutch setting, so that the 
results of this study may be valid for other countries. Furthermore, our Dutch evaluation 
of the eSET implementation problem could be an example for other settings as well. 
A second limitation is that we were not able to objectively measure the frequency of 
eSET use by each individual professional. In our current clinical practice, a couple 
undergoing IVF is treated by several professionals, which makes it impossible to link 
an individual professional to the specific choice of a couple for the number of embryos 
transferred. Therefore, we had to determine the hypothetical willingness for eSET. 
However, we measured a broad spectrum of values of professionals’ eSET willingness 
ranging from 0 to 100%, and this represents the expected differences in eSET attitude 
and use.14,16,19 A third limitation is that couples also participate in the decision for the 
number of embryos transferred, and they have a substantial impact on the decision 
since most Dutch IVF clinics allow this. Optimal implementation of eSET will probably 
not be achieved without taking barriers perceived by the patients into account. 
In conclusion, this study has identified the main perceived barriers to eSET use among 
IVF professionals, and it has shown that the university hospital of initial fertility training 
and the personal experiences of professionals substantially influence the willingness of 
professionals to perform eSET. With this knowledge, we could design an implementa-
tion strategy to increase eSET use and reduce the multiple pregnancy rate. Moreover, 
such a strategy could be most effective if barriers perceived by the patients were also 
taken into account.
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Abstract
 
BACKGROUND When deciding how many embryos to transfer during in vitro 
fertilization (IVF), clinicians and patients have to balance optimizing the chance of 
pregnancy against preventing multiple pregnancies and the associated complications. 
This paper describes the development and pilot test of a patient decision aid (DA) for 
this purpose.
METHODS The development of the DA consisted of a literature search, establishment 
of the format, and a pilot test among IVF patients. The DA development was supervised 
by a panel of experts in the fields of subfertility, obstetrics and DA-research and it was 
based on the criteria of the International Patient Decision Aid Standards.
RESULTS One Cochrane review and 34 articles were selected for the DA content. 
The DA presents information in text, summaries, tables, figures and through an 
interactive worksheet. The DA was reviewed positively and as acceptable for use in 
clinical practice by patients and professionals.
CONCLUSION The DA was thoroughly developed and is likely to be helpful for the 
decision-making process for the number of embryos transferred after IVF.
IMPLICATIONS FOR PRACTICE Physicians and researchers can use the DA without 
restriction in clinical practice or research related to decision-making.
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Introduction
Subfertility is a significant health problem and affects approximately 80 million couples 
globally.1 In vitro fertilisation (IVF) is an important treatment option for subfertile couples: 
more than 365,000 IVF cycles take place in Europe annually. Multiple pregnancies 
represent roughly a quarter of all pregnancies after IVF.2,3 There is extensive evidence 
of higher mortality and morbidity rates for both the mothers and neonates with 
multiple pregnancies than with singleton pregnancies.4-12 Long term consequences 
of these complications vary, but may result in life-long handicaps.13,14 Moreover, these 
complications of multiple pregnancies cause substantial use of medical budgets.15,16 
Prevention of multiple pregnancies after IVF is fairly easy to accomplish. If only one 
embryo is transferred instead of two or more, the incidence of multiple pregnancies 
will diminish to 0-1%.17-19 However, the use of elective single embryo transfer (eSET) 
could also reduce the pregnancy rate per IVF cycle.20-22 The difficult balance between 
an acceptable pregnancy rate and prevention of multiple pregnancies is probably why 
implementation of eSET in clinical practice has not been very successful. In Europe, 
single embryo transfer was used in only 19% of all IVF cycles in 2004.2 
How many embryos to transfer should ideally be decided in a shared decision-making 
process by an educated and empowered couple. We have previously explored this 
issue with IVF professionals and patients, who both agree that these requirements 
were not present in IVF care.23 Moreover, those requirements have been identified as 
important barriers to eSET use.20,24-27 Therefore, we have developed a decision aid 
(DA) to promote shared decision-making for the number of embryos transferred. 
DAs increase knowledge and support the decision-making process.28-32 They contain 
descriptions of treatment options and clarify risks and consequences of all options in 
text and visual form. Many DAs assist patients to determine and integrate their own 
preferences. This paper describes the development of the patient DA for the number 
of embryos transferred after IVF.
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Methods
Systematic approach
The DA development consisted of three steps: a literature search, selection of framework 
and format, and a pilot evaluation. An expert panel including subfertility specialists, 
epidemiologists, an obstetrician, an embryologist, an economist, and a DA researcher 
supervised the DA development.
Deciding how many embryos to transfer: Development and pilot test of a decision aid
eSET vs DET pregnancy rate
Pandian et al 200519 (Cochrane review)
Lukassen et al 200520 (local trial)
Gerris et al 199917 
Martikainen et al 200118
Thurin et al 200421
Van Montfoort et al 200622
Predictors of pregnancy with IVF
Templeton et al 199645
Smeenk et al 200047
Strandell et al 200049
Hunault et al 2002a51
Hunault et al 2002b53
Complication occurrence of twin and
singleton pregnancies after IVF
ESHRE Campus course 200136
Bryan et al 200337
Coonrod et al 199538
Dhont et al 19998
Ericson et al 200239
Helmerhorst et al 20044
Klemetti et al 200240
Koivurova et al 200241
Leslie et al 199842
Lieberman et al 199843
Mahskeed et al 199844
Murdoch et al 199846
Ochsenkuhn et al 200348
Pinborg et al 200350
Pinborg et al 2004a52
Pinborg et al 2004b10
Pinborg et al 2005a54
Pinborg et al 2005b5
Rao et al 200411
Rutter et al 200355
Scher et al 200213
Schieve et al 200212
Stromberg et al 200214
Westergaard et al 199956
Table I  Literature used for decision aid content
IVF = in vitro fertilisation; eSET = elective Single Embryo Transfer; 
DET = Double Embryo Transfer
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Literature Search
On the basis of our expert panel’s opinion and experiences of patients, we identified 
four domains that are important for a thorough decision for the number of embryos 
transferred: 1) optimizing the chances of pregnancy after eSET or double embryo 
transfer (DET), 2) factors predicting the chance of pregnancy, 3) the differences in 
complication rates for singleton and twin pregnancies and 4) the couples’ preferences 
in this decision. For the first three domains a literature search was performed to collect 
data for the content of the DA. At least two individuals independently evaluated the 
papers identified. The inclusion of papers was based on methodological quality and, 
if applicable, incidence and severity of the potential complications. We also included 
a randomized controlled trial (RCT) from our own centre, relevant to the first domain.20 
Thus, data regarding the chances of pregnancy mentioned in the DA were based on 
both local and international results. The format chosen for the fourth domain of personal 
preferences was determined on the basis of other DAs described in the literature.33
Selection of framework and format 
The DA was modelled on the Ottawa Decision Support Framework.34 The objective of 
the DA was to prepare couples for their upcoming decision-making process with their 
IVF professional. The DA explained the difficult balance between chance of pregnancy 
and complications associated with twin pregnancies in the course of a variable number 
of IVF cycles and it presented the information in a patient friendly format. The DA 
format was designed in concurrence with the checklist of the International Patients 
Decision Aid Standards, and consisted of 50 items divided over three domains.35 
Pilot evaluation
After our expert group, and employees of the patient association for subfertility in the 
Netherlands ‘Freya’, evaluated the DA, we pilot-tested it among seven couples with 
previous IVF experiences and three couples who were facing the decision for eSET or 
DET at that time. The seven experienced couples were recruited via the FREYA website 
and the three inexperienced couples were included from the IVF waiting list of our own 
centre. We evaluated the clearness, structure and relevance of the content, tables and 
figures of our DA with a questionnaire containing 23 items (20 Likert scale questions 
and three opportunities for improvement suggestions). 
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Results 
Findings systematic approach
Literature search
Of the 69 papers identified in our literature search, 35 informed the DA content (Table I). 
With respect to optimizing the chance of pregnancy after eSET or DET, we included 
one Cochrane review and five RCTs. We used five papers for the factors predicting 
chance of pregnancy and 24 papers reporting the differences in complication rates for 
IVF singletons and IVF twins. 
Framework and format
The DA contains three chapters. Chapter one describes optimizing the chances of 
pregnancy with eSET and DET and names the factors that predict chance of pregnancy. 
It shows that two IVF cycles with eSET have a chance of pregnancy similar to the 
chance with one DET cycle. Chapter two reports on the differences in complication rates 
of IVF singletons and IVF twins. Figure I integrates the information of both chapters. 
Chapter three provides an ‘action plan’, assisting couples with their decision for eSET 
or DET. This plan is supported with a worksheet (table II) to help couples explore their 
preferences in balancing the chance of pregnancy and risks of complications.
We structured the DA with short paragraphs containing a one or two sentence summary. 
Tables and figures present essential aspects. 
Findings pilot test
All patients approved the DA and most found it clear and well structured. After reading 
the DA, patients reported that they fully understood the pros and cons of eSET and 
DET. They also valued the DA as a good tool for improving the quality of IVF care. 
We observed no differences in opinion about the DA between the couples with IVF 
experience and the couples facing the decision for the number of embryos transferred 
at the time of evaluation.
The pilot test resulted in some improvements for the DA. For instance, we changed 
the order of chapters, used different terminology in tables, and chose to describe 
complications assuming that a viable pregnancy resulted from a transfer, rather than 
based on complication rates that begin accruing from the time of transfer. 
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Discussion and conclusion
Discussion
This paper described the development, including a pilot test, of a DA to foster shared 
decision-making between IVF professionals and subfertile couples when choosing the 
number of embryos transferred after IVF. 
Our evaluation demonstrated a thorough developmental approach. All participants in the 
pilot test evaluated the DA positively. However, the pilot test may not have been completely 
representative for all professionals and couples. The DA must be used extensively, by 
couples and professionals in the IVF field, before firm conclusions can be drawn. It will be 
important to observe the impact of the DA when it is used in clinical IVF practice, especially 
the effect on how many embryos are transferred and on the process of decision-making. 
A randomized controlled trial is currently underway to evaluate these effects. 
Conclusion
We have developed a DA for the decision for the number of embryos transferred 
after IVF. The DA appears useful for facilitating shared decision-making between IVF 
professionals and subfertile couples. However, its effects of the DA on the process of 
shared decision-making need to be further evaluated.
Practice implications 
Physicians and researchers can use the DA without restriction for clinical use or 
research related to decision-making. The DA is freely available on the internet at www.
umcn.nl/ivf-decisionaid. 
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Figure I  Chance of pregnancy with performing eSET twice versus 
DET once and the related obstetrical complications
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Abstract
 
BACKGROUND The decision for elective single embryo transfer (eSET) after in vitro 
fertilisation (IVF) will prevent multiple pregnancies with the associated complications 
for mothers and neonates. Couples may profit from support when facing the decision 
about the number of embryos transferred. We evaluated the effects of a multifaceted 
patient empowerment strategy on the actual eSET use.
METHODS A multifaceted strategy to empower couples in deciding how many 
embryos should be transferred was developed. The strategy consisted of a decision 
aid, support from an IVF nurse and a reimbursement offer for an extra IVF cycle. We 
performed a randomised controlled trial to compare the strategy versus no strategy. 
We included 308 couples on the waiting list for a first IVF cycle with a female age <40 
years. Primary outcome was the actual use of eSET in the first and second IVF cycle. 
Secondary outcomes were decision-making parameters and costs of the multifaceted 
strategy. 
FINDINGS After the first IVF cycle, 52% of the couples in the intervention group chose 
eSET, as did 39% in the control group (p<0·05). After the second IVF cycle, the eSET 
use was 26% versus 15% (p=0·15). Significant higher empowerment and knowledge 
levels, but no differences in anxiety or depression levels were identified in couples 
receiving the multifaceted strategy. Mean total savings in the intervention group were 
calculated to be €117·10 per couple.
INTERPRETATION This study illustrates that a multifaceted empowerment strategy 
can effectively encourage eSET use, increases patient knowledge, has no substantial 
side effects, reduces costs and could be an important tool to reduce the twin rate 
after IVF.
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Introduction
Patient empowerment is essential for good medical decision-making.1 It implies 
a process of informing patients and providing them with the necessary tools and 
autonomy to adopt an active role in decision-making. Patient empowerment is 
supposed to ensure that patients’ experiences and opinions are integrated into clinical 
decisions, as well as to encourage physicians and researchers to focus on patient-
centred outcomes.2 However, the effect of patient empowerment, especially within 
complex decision-making processes, is still being debated. Concerns were raised that 
patients might decline responsibility for decision-making or that they would choose for 
a suboptimal or the most expensive options.3,4
An example of a complex and important decision-making problem is the number of 
embryos transferred after in vitro fertilisation (IVF). The transfer of only one embryo 
if more are available, elective single embryo transfer (eSET), will prevent a multiple 
pregnancy with the associated complications for the mother and neonates.5-7 However, 
eSET may also be disadvantageous because it could result in a lower pregnancy rate 
per IVF cycle. Compared to multiple embryo transfer, this could imply a necessity for 
more cycles to achieve pregnancy.8-10 This balance between the risk for complications 
of multiple births and optimal chance of pregnancy, creates a complex decision-
making problem. Although professionals and policy makers have launched initiatives 
to encourage the use of eSET11, it has not been successfully implemented in clinical 
practice. In 2004, the European multiple pregnancy rate after IVF was still 23% and 
eSET was used in only 19% of all IVF cycles.12
Lack of knowledge about the pros and cons of eSET and the costs of the potentially 
necessary additional IVF cycles are important barriers for eSET use.13-15 Based on these 
barriers, we developed a multifaceted strategy to empower patients for the decision 
about the number of embryos transferred. This strategy consisted of an evidence-based 
decision aid, support of an IVF nurse and reimbursement of an additional IVF cycle for 
couples for whom the decision for eSET caused a reduced chance of pregnancy. Aim 
of this study was to evaluate the effects of this multifaceted empowerment strategy on 
the actual number of embryos transferred. In addition, we evaluated the impact on the 
decision-making process and on costs related to the strategy. 
Chapter 7
7
120
Methods
Setting
In the Netherlands IVF, including intracytoplasmic sperm injection, is performed in 13 
licensed hospitals: eight university hospitals, four general hospitals, and one private 
clinic. In a hospital without a licence, professionals can start up and monitor IVF and 
refer to a licensed hospital for the oocyt retrieval and embryo transfer. The current 
average pregnancy rate per IVF cycle in the Netherlands is about 24%.16 Most couples 
who do not achieve pregnancy after a first IVF cycle undergo successive cycles. The 
Dutch national healthcare system reimburses the costs of the first three fresh IVF 
cycles, but only if maximally two embryos are transferred. Before the start of this trial, 
it was standard practice in the participating centres that the couple and their physician 
shared the decision-making process between eSET and double embryo transfer (DET). 
By then (2005) 39% of the couples received eSET after the first IVF cycle.17
Design, participants and sample size
The randomised controlled trial (RCT) was designed to test the hypothesis that a 
multifaceted empowerment strategy could encourage the use of eSET and reduce the 
number of twin pregnancies in a cost-effective way. The trial compared the multifaceted 
patient empowerment strategy on top of standard IVF practice with standard IVF 
practice only. 
Our RCT was performed in two licensed hospitals and three associated clinics and 
included couples on the waiting list for IVF between November 2006 and July 2007. 
Follow-up was continued until December 2008. The clinical trial protocol was approved 
by all institutions’ ethical boards. The trial is registered with Clinical trials.gov, number 
NCT00315029. All couples provided written informed consent before participation. The 
criteria for inclusion were: couples on the waiting list for a first IVF cycle ever or a 
first cycle after previous successful IVF with the women younger than 40 years. A 
strict medical indication for preventing twin pregnancies (anomalies of the uterus, for 
example) made a single embryo transfer mandatory, and was therefore an exclusion 
criterion. 
The randomisation took place centrally with the use of a randomisation list. 
Participants were randomised in blocks of four couples. A secretary worker outside 
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our IVF department allocated the couples and was the only person having access to 
the randomisation list. Blinding the participants to the allocation was not applicable, 
because of the nature of the intervention. Physicians and researchers did not know the 
participants’ allocation and there were no changes in their routine.
To detect a 25% difference in eSET use between intervention and control group, with 
an alpha of 0·05, two-sided testing and a power of 0·80, we needed to include at least 
220 couples eligible for analysis. Because participants were included and randomised 
before the IVF treatment began, not all couples started with IVF (for instance, because 
of a spontaneous pregnancy or ending of the relationship). Moreover, only data for 
couples who had at least two embryos available for transfer were analysed, because 
couples with fewer than two embryos will not decide between eSET and DET. Taking 
these potential reasons for dropout into account, we aimed for approximately 300 
couples for inclusion. 
Interventions
The control group received standard IVF care, including a session in which the number 
of embryos transferred was discussed. In addition to the standard IVF care, the 
intervention group was sent a decision aid about the decision for the number of embryos 
transferred (www.umcn.nl/IVF-decisionaid). The decision aid was developed according 
to the criteria of the International Patient Decision Aids Standards Collaboration 
(IPDAS).18 The couples also received a reimbursement offer for an additional fourth 
IVF cycle. This reimbursement was applicable only if the couple chose eSET in the first 
and second IVF cycle and no pregnancy occurred. Subsequently, the content of the 
decision aid and the reimbursement offer were discussed with a trained IVF nurse in 
person. These three elements of the strategy were all provided prior to the standard 
counselling session of the standard IVF care. The last element of the strategy was a 
phone call from the IVF nurse just before pick up of the oocytes used to discuss any 
relevant questions that might have arisen during the IVF treatment.
Outcome measurements
Primary outcome was the actual use of eSET or DET (the number of embryos 
transferred) in the first and second IVF cycle. Secondary outcomes were the IVF 
treatment outcomes, parameters of the decision-making process and cost evaluation 
of the multifaceted empowerment strategy. Data about the number of embryos 
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transferred, background characteristics (female age, primary or secondary infertility, 
duration of infertility, and cause of infertility), and the IVF treatment outcomes were 
collected via the local IVF registry. The decision-making outcomes were measured with 
validated questionnaires. The participants received the first questionnaire at inclusion, 
a second after the intervention (but before starting IVF) and the third five weeks after the 
embryo transfer. We used the General Self-Efficacy Scale to obtain the empowerment 
levels.19 Experienced subjective and actual knowledge levels were measured by self 
grading and an eleven item multiple choice test, respectively. We monitored Decision 
Evaluation Scores by means of a 15 item questionnaire, that included three domains; 
satisfaction–uncertainty, informed choice and decision control.20 We determined anxiety 
and depression levels with the State-Trait Anxiety Inventory21 and the Beck Depression 
Inventory.22 
Aim of the cost evaluation was to provide insight into the costs associated with 
 implementation of the multifaceted empowerment strategy in clinical IVF practice. 
The evaluation was performed from a healthcare perspective and calculated the 
difference in total costs per couple between the intervention and control group. Protocol 
driven costs for this specific trial, including costs of the development of the decision 
aid were excluded. The following costs were included: (1) costs associated with all 
elements of the intervention (printing and distribution of the decision aid, costs of the 
IVF nurse and costs of the reimbursement offer), (2) the medical costs associated with 
additional IVF cycles necessary to compensate for reduction in chance of pregnancy 
due to eSET use, and (3) the costs associated with the difference in frequency of 
singleton and twin pregnancies. Regarding the intervention costs, print and postal 
costs of the decision aid were determined from actual expenses. Costs of the IVF nurse 
were based on actual training hours and timing of the counselling sessions. Prices 
were determined from guidelines for cost-related research in the Netherlands.23 For the 
surplus of couples in the intervention group who did not become pregnant compared 
to the couples in the control group, we calculated the costs for the additional IVF 
cycles based on the assumption that couples needed an average of 1.5 IVF cycles 
compensation after a failed first cycle and one cycle compensation after a second 
failed IVF cycle. The couples in the intervention group who had chosen eSET in the first 
and second IVF cycle and who were not pregnant after three cycles in total, qualified 
for reimbursement of a fourth cycle. These costs were included as well. Costs per IVF 
cycle and per singleton or twin pregnancy were determined from a previous analysis at 
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our department; an IVF cycle costing €2,071, a singleton pregnancy €2,788 and a twin 
pregnancy €14,727.24 We adjusted all unit costs to 2008 Euros by using the Consumer 
Price Index as published by the Central Bureau of Statistics in the Netherlands (http://
statline.cbs.nl/statweb). 
Statistical analysis
We analysed the background characteristics of the intention-to-treat population. 
The other (per protocol) analyses took place within the population that actually started 
IVF and had at least two embryos available. The eSET or DET use in the first IVF cycle 
as well as the ongoing pregnancy (defined as a viable pregnancy with >12 weeks 
gestation) and twin pregnancy rates were described for both study groups and tested 
for statistical differences using the chi-square test. P values <0·05 were considered 
statistically significant. We performed multivariate regression analysis to identify 
potential confounders for the difference in eSET use. We added female age (years), 
presence of a good quality embryo (yes/no), duration of infertility (years) and previous 
pregnancies (yes/no) to the model with eSET use as the dependent variable. For the 
empowerment scale, we dichotomised the original five point Likert-scale, combining 
the two categories in which participants wanted to decide for themselves as 1) fully 
empowered (‘wanting to make the decision with the physician only as an advisor’) and 
the other categories as 2) not fully empowered (‘wanting to make the decision with 
the physician as a decision-maker as well’). Experienced and actual knowledge were 
expressed by means and 95% confidence intervals. For each of the three domains of 
the Decision Evaluation Scale, we calculated a sum score and presented the mean 
and 95% confidence interval. We applied the same sum score procedure to the 
anxiety and depression items. Additionally for the depression level this sum score was 
dichotomised as 1 (no depression) and 2 (subclinical depression) at a cut-off level of 
four. 25 We used SPSS, version 16.0.01, Chicago, Ill., for the statistical analyses. 
Results
Study population
Figure I shows the trial’s flowchart. Written consent from 344 couples was received and 
308 couples were randomised, because 36 couples had already started IVF. Of the 
308 couples, 275 were included in the intention-to-treat analysis, because 33 couples 
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Figure 1 Trial profile
344 couples eligible  
for inclusion 
308 randomised
275 included in 
intention-to-treat 
analysis
36 not included 
•  already started IVF at 
consent
33 excluded 
• 20 pregnant before start IVF
• 13 never started IVF
136 assigned  
to standard care
23 not included in analysis
•  Less than 2 embryos 
available
Analyzed (n=113)
139 assigned to standard 
care plus intervention
30 not included in analysis
•  Less than 2 embryos 
available
Analyzed (n=109)
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did not commence with IVF. Table I describes the background characteristics of this 
population. No relevant differences were observed between intervention and control 
group. After oocyte retrieval and fertilisation, 222 couples had more than one embryo 
available for transfer and remained eligible for the analysis. 
Effectiveness
Table II shows the actual use of eSET and the number of ongoing and twin pregnancies 
after the first IVF cycle. In the intervention group 52% chose eSET, compared with 39% 
in the control group (p<0·05). The result of the multivariate analysis demonstrated that 
the odds ratio for this 13% difference did not change after addition of the potential 
confounders (like female age or the presence of a good quality embryo). We identified 
seven more ongoing pregnancies in the control group than in the intervention group 
(p=0·46), but four more twin pregnancies as well (p=0·34). In the second IVF cycle 
26% of the couples in the intervention group received eSET, compared to 15% 
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  Intervention group  Control group
 n=139 n=136 
Mean female age in   32.0  32.0 
years (SD) (3.9) (3.9)
Mean duration of infertility in  2.2  2.4 
years (SD) (1.9) (2.1)
% Primary infertility 66 66
% IVF 51 45
% ICSI  49 55
Diagnostic categories of infertility
% Male factor 60 67
% Unexplained 24 15
% Endometriosis 5 7
% Tubal factor 6 5
% Other 5 6
SD = Standard Deviation; ICSI = Intra Cytoplasmic Sperm Injection; IVF = in vitro fertilisation
Table I  Characteristics of the participating couples
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in the control group (p=0·15). After the second IVF cycle two additional ongoing 
pregnancies occurred in the control group, 16 versus 14 (p=0·62), but also two extra 
twin pregnancies, six versus four (p=0·67).
Table III illustrates the parameters related to patient empowerment in both groups. 
The proportion of couples in the intervention group who wanted to decide for the 
number of transferred embryos themselves (with the physician only as their advisor) 
increased from 77% to 90%, while this percentage remained at 73% in the control 
group (p=0·02). The Decision Evaluation Scale showed no significant differences in 
satisfaction-uncertainty or control levels, but couples in the intervention group reported 
a better informed choice (p=0·03). This persisted until five weeks after the embryo 
transfer (p=0·02). No significant differences between the two groups were observed in 
anxiety levels or frequency of subclinical depression.
Costs
Costs of the elements of the multifaceted patient empowerment strategy were added 
to the savings due to a lower twin pregnancy rate. The mean total costs per couple 
are demonstrated in table IV. Costs of the counselling session with the IVF nurse were 
based on an average duration of the counselling session of 32 minutes and two minutes 
for the telephone call. Six of the 139 couples in the intervention group received eSET in 
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 First IVF cycle Intervention group  Control group p value
 n=109 n=113  
eSET use  57 44 
<0.05
(%) (52%) (39%)
ongoing pregnancies* 41  48  
0.46
(%) (38%) (43%)
Twin pregnancies 6 10 
0.34
(%) (6%) (9%)
* Defined as > 12 weeks gestation
eSET = elective Single Embryo Transfer; IVF = in vitro fertilisation
Table II  Elective single embryo transfer use and pregnancies after  
the first IVF cycle
127
Chapter 7
7
 
 
In
te
rv
en
tio
n 
G
ro
up
 
 
C
on
tr
ol
 g
ro
up
 
B
as
el
in
e 
A
ft
er
 in
te
rv
en
tio
n 
 
B
as
el
in
e 
B
ef
or
e 
st
ar
t I
VF
 
 
(b
ef
or
e 
st
ar
t I
VF
)
%
 fu
lly
 e
m
po
w
er
ed
 
77
%
 
90
%
* 
 
71
%
 
73
%
*
M
ea
n 
kn
ow
le
dg
e 
(9
5%
 C
I)
 
E
xp
er
ie
nc
ed
 
5.
8 
(5
.4
-6
.2
) 
7.
6 
(7
.4
-7
.8
) 
 
5.
9 
(5
.4
-6
.3
) 
7.
2 
(7
.0
-7
.5
)
A
ct
ua
l 
. 
6.
8*
 (6
.3
-7
.3
) 
 
. 
4.
9*
 (4
.6
-5
.2
)
M
ea
n 
de
ci
si
on
 e
va
lu
at
io
n 
le
ve
ls
 (
95
%
 C
I)
S
at
is
fa
ct
io
n-
un
ce
rt
ai
nt
y 
. 
4.
0 
(3
.8
-4
.1
) 
 
. 
4.
0 
(3
.9
-4
.1
)
In
fo
rm
ed
 C
ho
ic
e 
. 
4.
1*
 (4
.0
-4
.2
) 
 
. 
3.
8*
 (3
.7
-3
.9
)
C
on
tro
l 
. 
4.
4 
(4
.2
-4
.5
) 
 
. 
4.
5 
(4
.4
-4
.6
)
A
nx
ie
ty
 le
ve
l 
34
.9
 (3
3.
0-
36
.8
) 
35
.9
 (3
3.
9-
37
.9
) 
 
33
.3
 (3
1.
7-
35
.0
) 
34
.5
 (3
2.
9-
36
.1
)
%
 s
ub
cl
in
ic
al
 d
ep
re
ss
io
n 
11
%
 
9%
 
 
6%
 
5%
* 
p 
<
 0
.0
5,
 C
I =
 C
on
fid
en
ce
 In
te
rv
al
; I
VF
 =
 in
 v
itr
o 
fe
rti
lis
at
io
n
Ta
b
le
 I
II
 
 d
ec
is
io
n-
m
ak
in
g
 o
ut
co
m
es
128
the first and second IVF cycle and did not achieve pregnancy after three cycles in total. 
They therefore qualified for reimbursement of the fourth IVF cycle. After computing all 
costs of this trial, mean total savings in the intervention group were calculated to be 
€117·10 per couple included from the IVF waiting list.
Discussion
This study presents an effective multifaceted empowerment strategy to encourage 
eSET use in clinical IVF practice. The strategy consisted of a decision aid, support 
Patient empowerment for prevention of twins pays off; a randomized controlled trial
Elements of costs Costs per couple* 
 (in euros) 
Elements of the empowerment strategy
Decision aid
- print costs decision aid 8.70
- mail costs decision aid 0.45
IVF nurse†
- training of IVF nurse (16 hours in total) 3.35
- counselling session 103.60
- phone call 6.50
Reimbursement offer‡
- reimbursed 4th cycles   89.40
Medical related costs 
-  extra IVF cycles to compensate for loss in chance of  186.25
  pregnancy after eSET use
Obstetrical cost reduction¶
- six less twin pregnancies -515.35
  Savings of
Total savings €117.10 per couple
* Total costs divided by 139 couples in the intervention group
† Based on Oostenbrink 2004 et al23
‡ Based on six couples that qualified for reimbursement (total costs 12,426 Euro)
¶ Based on six fewer twin pregnancies after the first and second IVF cycle
Table IV  Costs of the multifaceted patient empowerment strategy  
per couple in IVF practice
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of an IVF nurse and a reimbursement offer. The strategy also significantly increased 
the empowerment level of the couples regarding the decision-making process for the 
number of embryos transferred and increased actual and experienced knowledge 
about important aspects of the decision. No adverse effects, such as increased anxiety 
and depression levels, were observed. Within this trial the strategy reduced costs with 
an average of €117·10 per couple. If these savings would be extrapolated to the Dutch 
national level, with 7,500 new couples per year, this reduction would add up to €878,250 
annually. With national implementation one could expect additional costs, for instance 
costs related to keeping the information in the decision aid up to date. However, with 
broad implementation the printing and training costs per couple will reduce remarkably 
and are likely to at least compensate for these additional costs.
The results of this study are interesting in several ways. First, it shows that patient 
empowerment for IVF couples can lead to marked effects on the actual decision for 
the number of embryos transferred. Such a clear difference in outcome with an imple-
mentation strategy solely for patients is rare.26,27 This may be due to the fact that the 
elements of our strategy were specifically based on barriers reported by couples and 
professionals in previous studies.13,14,17 The positive results of this study are even more 
remarkable when we consider that IVF professionals are still debating the necessity of 
preventing twin pregnancies with eSET.13,28,29 One could claim that patients might be 
more suitable to obtain implementation of eSET than professionals. Second, with the 
empowerment strategy, 90% of the couples wanted to take the decision for the number 
of transferred embryos themselves (with their physician as an advisor only). Patients 
are apparently eager and capable to take complex decisions like this, once they have 
received proper support. Third, we anticipated a prominent role of the reimbursement 
offer within the strategy, but actually it did not. A considerable number of couples did 
not qualify for reimbursement because they chose DET after the first or second IVF 
cycle. Only 4% of the couples (six of 139 couples in the intervention group) qualified for 
reimbursement and at present only two couples have actually received such a fourth 
IVF cycle. Finally it should be noted that the empowerment strategy was not designed 
to prevent twin pregnancies to occur, but to support the decision-making process. 
Although this study demonstrates a higher proportion of couples deciding for eSET, 
still half of them decided to transfer two embryos after the first IVF cycle. However, we 
have noticed an increase in couples’ capability to take an informed decision. Perhaps if 
couples are empowered for this decision and comprehend the pros and cons of eSET, 
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the strategy is already a success and one could argue about the desirability of further 
encouragement of eSET use.
Obviously, it is very important to consider the setting in which the multifaceted 
empowerment strategy is used. Globally, IVF is used in different contexts which can 
greatly influence the effects of such a strategy. For instance, with legislation prohibiting 
the transfer of more than one embryo30,31, this strategy is probably of little value. Still, 
most countries do not have compulsory single embryo transfer legislation and previous 
research has shown that even with such legislation, total acceptance of single embryo 
transfer could not be achieved.32 Another contrast in setting could be the magnitude 
of patient autonomy within the process of shared decision-making. There are large 
discrepancies in how much of a say couples actually have in decision-making between 
countries and even clinics. In settings granting less patient autonomy than in our 
participating centres, the results of our strategy might be less pronounced. A final 
important difference in setting might be that Dutch health insurance reimburses three 
IVF cycles. The results of the strategy could be very different in a setting with less or 
no reimbursed cycles, especially since the absence of reimbursement is an incentive 
to transfer more embryos.15 But even then, we can expect that educated couples, who 
understand the risks of twin pregnancies, will be more inclined to choose for eSET.
Although strong points of our study were that the strategy was tailored for the barriers 
identified with our previous research13,14,17 and that the decision aid was developed 
according to the evidence-based criteria of the IPDAS Collaboration18, this study also 
has some potential weaknesses. A first potential weakness is the national basis of 
our strategy. Dutch IVF professionals and couples may perceive barriers that are 
different from those perceived elsewhere. Nonetheless, most of these barriers are not 
specifically related to the Dutch situation, so that the results of this study are probably 
valid for other countries as well. Another potential weakness is the limited follow-up in 
our trial. At present, not all couples have finished all their IVF cycles and do not know 
how IVF will turn out for them. 
 
We infer from this study that patients are willing and able to take complex decisions if 
they are empowered to do so, as long as they are provided with the right information 
in the right way in a setting with patient autonomy. Implementation of this multifaceted 
empowerment strategy could also help IVF professionals as it contributes to a more 
Patient empowerment for prevention of twins pays off; a randomized controlled trial
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efficient decision-making process and a reduction of costs. More research is welcomed 
to determine the effectiveness of the multifaceted empowerment strategy in other 
national settings and to determine which elements of the strategy contributes most to 
its effectiveness.
In conclusion, this study illustrates that a multifaceted empowerment strategy 
can effectively encourage eSET use in clinical IVF practice. The strategy increases 
knowledge, has no substantial side effects, reduces costs and could be an important 
tool to reduce the twin rate after IVF, within a setting with patient autonomy.
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Abstract
BACKGROUND A quarter of all pregnancies after in vitro fertilisation (IVF) are twins, 
with increased probability for maternal and neonatal complications compared to 
singletons. Elective single embryo transfer (eSET) is an important option to prevent 
twins. We evaluated the relation between eSET use and exposure to specific elements 
of an effective multifaceted strategy, consisting of a decision aid (DA), two sessions of 
support of an IVF nurse (a counselling session and a phone call) and a reimbursement 
offer. Additionally, we determined couples’ experiences with these elements.
METHODS An observational study was performed among 222 subfertile couples. 
A multivariate regression analysis was used to determine the influence of specific 
strategy elements on the decision for the number of embryos transferred. Question-
naires evaluated the experiences of couples with the different elements. 
RESULTS Couples who had received the support of the IVF nurse did no use eSET 
more often, compared to couples that only received the DA and reimbursement offer. 
The couples experienced the reimbursement offer and the phone call as less important 
for their decision compared to the DA, the counselling session and physician’s advice 
(p < 0,001).
CONCLUSIONS We found no evidence for increased effectiveness of the multi-
faceted strategy with adding more elements. Moreover, couples evaluated the DA, 
the counselling session with an IVF nurse and their physician’s advice as the most 
important elements for their decision for the number of embryos transferred. 
PRACTICE IMPLICATIONS Our evaluation revealed that a simplified strategy seems 
just as effective for encouraging eSET use compared to a multifaceted strategy.
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Introduction
Subfertility is an important health problem, affecting approximately 80 million couples 
around the globe.1 For subfertile couples, in vitro fertilisation (IVF) is often the final 
possibility to conceive. An IVF treatment cycle consists of ovarian stimulation, pick up 
of oocytes, fertilisation in the laboratory and finally the transfer of a number of embryos 
into the uterus. The average number of embryos transferred in Europe varies between 
countries, but is often more than one.2,3 Currently, after an IVF cycle, 20-25% of all 
pregnancies turn out as twin pregnancies, compared to only 0-1% of pregnancies 
in the population without subfertility treatment.4,5 Twin pregnancies are associated 
with higher morbidity and mortality rates for both mother and neonates, compared 
to singleton pregnancies. Examples of complications with a higher occurrence are: 
a longer stay in hospital or NICU department, (pre-)eclampsia, caesarean sections, 
premature births and (very) low birth weight.5-8 As a result of these elevated risks, the 
medical costs for twin pregnancies are approximately €11,000 higher per pregnancy, 
and even estimated as €30,000 higher if life-long costs for handicaps are included.9,10 
Elective single embryo transfer (eSET) is the most important option to prevent twin 
pregnancies after IVF, it reduces the twin incidence to 0-1%.5 Unfortunately, transferring 
one embryo could decrease the pregnancy rate per IVF cycle as well.8,11,12 Therefore, 
subfertile couples using eSET may need more IVF cycles to eventually become 
pregnant. This balance, between the prevention of complications associated with twin 
pregnancies and optimal chance of pregnancy, could be one of the main reasons why 
eSET is still not widely used in clinical practice. In 2004, the single embryo transfer use 
in Europe was only 19% of all IVF cycles.2 
To improve the use of eSET in current clinical practise, we previously performed a 
randomised controlled trial (RCT) to test a multifaceted implementation strategy. This 
strategy significantly increased the eSET use with 13%  and was based on known barriers 
for eSET use.13-15 The strategy consisted of four elements: a decision aid (containing 
information about chances on and risks of singletons versus twin pregnancies), two 
sessions of support of an IVF nurse (a counselling session and a phone call) and a 
reimbursement offer for an additional IVF cycle for couples for whom the decision for 
eSET had reduced the chance of pregnancy (figure I). 
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The results of this RCT are promising, but the question remains if every strategy 
element contributed equally to its effectiveness. With multifaceted strategies, it is 
always possible that participants do not receive the complete strategy as planned. 
So, couples in our RCT may not have been exposed to all specific strategy elements. 
Evaluating couples’ actual exposure to the different strategy elements might give us the 
opportunity to assess which elements of the implementation study contributed mostly 
to the effectiveness of the strategy, increasing the eSET use. Moreover, before applying 
the multifaceted strategy on a large scale, it is important to gain insight in couples’ 
In depth evaluation of an effective multifaceted implementation strategy for eSET after IVF
Figure I Elements of the multifaceted strategy
Start IVF treatment 
Embryo Transfer
Decision Aid
Reimbursement offer
Counselling by IVF nurse
Phone call by IVF nurse
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experiences with the different strategy elements as well. Negative experiences could 
prohibit the future implementation of effective strategy elements. Information about the 
effectiveness of the different elements and experiences with these elements could also 
help to modify the strategy, by making it more effective and less expensive.16,17 
Therefore, aim of this study was to evaluate the relationship between eSET use 
and couples’ exposure to the different elements of the multifaceted implementation 
strategy. Moreover, we determined couples’ experiences with these different strategy 
elements. 
Methods
Design and study population
We performed an observational study to determine the effectiveness of a multi-
faceted implementation strategy. This study was based on our previously performed 
RCT. Inclusion criteria for participation were: couples undergoing a first IVF cycle and 
female age < 40 years. An exclusion criterion was a strict medical indication for single 
embryo transfer. The control group (113 couples) received standard IVF care, including 
a preparatory session in which the number of embryos transferred was discussed. 
In addition to the standard IVF care, the intervention group (109 couples) received 
the multifaceted implementation strategy. This multifaceted implementation strategy 
consisted of four elements: a decision aid, a reimbursement offer and two sessions of 
support of the IVF nurse (a counselling session and a phone call).
In this study, we evaluated the multifaceted implementation strategy within three 
domains: 1) couples’ exposure to the different strategy elements ant the relation with 
actual eSET use, 2) couples’ self-rated importance of the influence of the specific 
elements on their decision for transferring one or two embryos and 3) couples’ 
 appreciation of the different elements of the implementation strategy. 
Data collection
The main effect parameter of our study was the eSET use of couples receiving 
different elements of the multifaceted implementation strategy. Data on couples’ 
eSET use, couples’ exposure to the different elements of the strategy and their 
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baseline  characteristics were collected from the original randomised controlled trial’s 
data bases. These databases were originally constructed from IVF registries and 
patients’  questionnaires.
Couples’ experiences with the strategy elements were also obtained from the 
 questionnaires. A 5 point Likert scale was used to determine the couples’ opinion 
concerning the influence of the specific strategy elements on their final decision for the 
number of embryos transferred (1 =  ‘not important for our final decision’, to 5 = ‘very 
important for our final decision’). With a similar Likert scale approach, couples were 
also asked to rate the influence of their physician’s advice on this decision as well. 
Additionally, we evaluated the couples’ appreciation per strategy element on another 
5 point Likert scale (1 =‘We definitely do not appreciate the strategy element’, 5 = ‘We 
appreciate it very much’). Evaluation of appreciation was measured within different 
domains: general appreciation, comprehensibility, amount of necessary time investment 
(in minutes) and availability of all relevant information for the couple’s decision for the 
number of embryos transferred. 
Statistical analysis
To analyse the relationship between eSET use and exposure to the strategy elements, 
we divided the participating couples into classes of exposure. Frequencies and means 
of eSET use, female age, duration of subfertility, type of subfertility and availability of 
a good embryo for transfer, were determined to compare differences in use of eSET 
and differences in baseline characteristics between the classes of exposure. We used 
a multivariate binary logistic regression analysis with the enter method to evaluate the 
impact of exposure to the different strategy elements on the use of eSET. In the multi-
variate analysis, we expressed the decision for eSET as the dependent variable. Those 
baseline characteristics that differed between the exposure classes were integrated as 
covariates to correct for possible confounding. 
The couples’ self rated importance of the different strategy elements compared to 
the impact of their physician’s advice on their decision for transferring one or two 
embryos, was tested. A linear mixed model calculated the average scores per element 
and tested these five mean scores of self rated importance for significant differences. 
A P value < 0.05 is suggested to be statistically significant. 
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Differences in couples’ appreciation of the four strategy elements were determined 
by calculating frequencies per domain of appreciation. Other experiences with the 
strategy elements, as reading time for the decision aid, were expressed by their mean 
values. Statistical Products Services and Solutions (SPSS) version 16.0.1, was used 
for these statistical analysis. 
Results
Exposure
Evaluation of couples’ exposure to the different elements of the multifaceted 
 implementation strategy revealed that couples could be divided in four classes of 
exposure. Group 0, the control group, received no elements of the strategy at all 
(N=113). Group 1 only received the decision aid and the accompanying  reimbursement 
offer (N=20). Group 2 received the same two elements as group 1 and additionally 
discussed the content of the decision aid with the IVF nurse (N=37). And finally, 
couples in group 3 received the multifaceted strategy, as was intended; the decision 
aid, the reimbursement offer and two sessions with the IVF nurse (N=52). 
Table I demonstrates the eSET use and baseline characteristics of the couples in the 
four different exposure groups. The difference in eSET use between group 1 and group 
0 was 31%  (70% versus 39%; p=0,01). The difference in eSET use in group 2 and 3 
decreased compared to group 1 with 21% (p=0,13) and 22% (p=0,10), respectively. 
The baseline characteristics, ‘availability of a good quality embryo’ and ‘secondary 
subfertility’ (a previous pregnancy), differed between the exposure groups as well. 
After correction for these baseline characteristics in the multivariate analysis, a trend 
of more eSET use in group 1 compared to group 0 persisted (p=0.07), but weakened. 
The differences between the groups 2 and 3  versus group 1 also weakened (p=0.23 
for group 2 versus group 1 and p=0.26 for group 3 versus group 1) Overall, the two 
sessions with the IVF nurse showed no additional benefit for eSET use compared to the 
decision aid and the reimbursement offer.
Experiences: importance of different strategy elements
Figure II shows the average self rated importance of the different strategy elements, as 
well as the score for their physician’s advice, on the couples’ decision for the number 
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 Exposure group 0 1 2 3
N  113 20 37 52
% eSET use 39  70 49 48
Characteristics
Mean female age (years) 32 32 31 32
Mean duration of subfertility (years) 2 2 2 2
% secondary subfertility 38 47 27 35 
% couples with an embryo of good quality 64 85 73 71
Group 0 Control group    
Group 1 Couples received the Decision Aid the reimbursement offer
Group 2 Couples received the same elements as group 1  
 AND counselling of the IVF nurse
Group 3 Couples received the same elements as group 2  
 AND a phone call from the IVF nurse
eSET = elective Single Embryo Transfer
Table I  eSET use among groups of couples exposed to a different 
number of strategy elements
5
4
3
2
1
Physician’s
advice
Decision Aid Counseling by
an IVF nurse
Phone call Reimbursement
offer
Important
Unimportant
Very unimportant
Neither important 
nor unimportant
Figure II  Importance of strategy elements compared te physician's advice 
for the decision for the number of embryos transferred
145
of embryos transferred. Couples rated the physician’s advice, the decision aid and the 
counselling by the IVF nurse as most important for their decision for the transfer of one 
or two embryos. The two remaining strategy elements, the phone call of the IVF nurse 
and the reimbursement offer, were classified as significantly less important (p<0.001). 
Moreover, the reimbursement offer was evaluated as even less important for couples’ 
decision for the number of embryos transferred compared to the phone call of the IVF 
nurse (p<0.001).
Experiences: appreciation of different strategy elements
Table II shows that couples were more positive about the decision aid and the 
counselling by the IVF nurse, compared to the telephone call and the reimbursement 
offer. Ninety percent of the couples appreciated the decision aid and the counselling by 
the IVF nurse, compared to sixty to seventy percent of the couples which appreciated 
the phone call and the reimbursement offer, respectively. Moreover, couples believed 
that the decision aid and the counselling session reached their goals, enabling 
them to make a fully informed decision. Most couples thought that the decision aid 
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 Decision Counselling Phone Reimbursement
 aid by IVF nurse call offer
The element:
was appreciated 91% 88% 56% 67%
was comprehensible 98%   88%
took the right amount  93% 86%
of time
was provided in the right  98% 84%
manner
discussed all relevant  80% 76%
information
has reached its goal 81% 84% 54% 66%
is a useful addition to the   93% 55%
decision aid
Table II  Experiences with the specific strategy elements
eSET = elective Single Embryo Transfer
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contained all relevant information and that it was written in a comprehensible manner. 
The average time it took a couple to read the decision aid was 36 minutes (95% CI: 
11-89 minutes) and couples did not experience this as troublesome. Over ninety 
percent of the couples believed that the counselling by the IVF nurse was a valuable 
addition to the decision aid and most of them did not mind an extra visit to the clinic. 
Moreover, couples did not object to counselling by a nurse, half of the couples even 
preferred to discuss the content of decision aid with a nurse instead of a physician.
Discussion
Evaluation of couples’ exposure to the different elements of our multifaceted 
 implementation strategy reveals that, as usual, not all couples received all strategy 
elements as planned.16 
Multivariate analysis showed that two sessions with the IVF nurse had no additional 
benefit for eSET use compared to the decision aid and the reimbursement offer. It 
even seems that the eSET use decreases with the addition of support by an IVF nurse. 
This could be explained as follows. First, couples may have been persuaded to transfer 
more embryos during the counselling session of the IVF nurse. Her experience with 
current IVF might have caused an unintended advice to transfer two embryos. Second, 
couples in group 1 could have selected themselves as couples who had no interest in 
the support of the IVF nurse. A third explanation could be the explanation of Grimshaw 
et al.; adding elements to a simple implementation strategy does not always result in 
an increased effectiveness.18 
With respect to couples’ self rated importance of the different strategy elements, 
couples felt that besides their physician’s advice, the decision aid and the counselling 
session with the IVF nurse were most important for their decision for the number of 
embryos transferred. This creates an interesting consideration. Couples regard the 
counselling session with the IVF nurse as important for their decision, but it does not 
seem to contribute to encourage the eSET use. From a patient-centred point of view, 
the counselling session may complement the decision aid in providing the couples with 
the support they need, to make a decision which they regard as right in their particular 
physical, emotional and social situation. With this focus, a future  implementation 
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strategy for eSET should include a counselling session with an IVF nurse. From a 
societal or economic point of view, a future implementation strategy for eSET does 
not need the counselling session with the IVF nurse. It could only consist of a decision 
aid and a reimbursement offer, because this will result in an increased eSET use and 
therefore in less twin pregnancies and lower costs. 
With respect to the reimbursement offer, couples regarded it as the least important 
element of all strategy elements. Unfortunately, it was impossible to assess eSET use 
for the reimbursement offer apart from the decision aid, because they were offered 
to the couples in one post package. However, the results of our evaluation suggest 
that the reimbursement offer neither contributes to the increase in eSET use, nor is 
of importance for couples’ decision for the number of embryos transferred. This is 
in contrast with previous research, that demonstrated that insurance coverage or 
 reimbursement could lead to the transfer of fewer embryos per cycle.13,19 This difference 
in result might be explained by differences in reimbursement systems. Couples 
undergoing IVF in many other countries might have limited or no compensation of IVF 
costs, while the Dutch national healthcare system currently reimburses the costs of the 
first three fresh IVF cycles. Dutch IVF couples might not feel the need for additional 
reimbursement on top of their standard IVF insurance coverage. Another explanation 
for our result could be that IVF couples do not think about the possibility of a fourth 
IVF cycle at the start of their IVF treatment, because they hope to be pregnant within 
three cycles. However, reimbursement might play a greater role in IVF care in the near 
future. In the Netherlands, the price of an IVF cycle has almost doubled recently 
and, especially in light of the current financial crisis, this could have an effect on 
 appreciation of the reimbursement offer.
 
Our study is an example of an in depth evaluation of a multifaceted implementation 
strategy. Previous research, on the effectiveness of different elements of multifaceted 
intervention studies or of guideline implementation, is rare. However, it is important 
to asses which strategy elements contributes most to its effectiveness. This could 
lead to the omission of unnecessary strategy elements, making the implementation 
of the strategy simpler and less expensive.16,17 However, there might be limitations 
to our evaluation as well. The optimal method to evaluate the impact of four strategy 
elements is to evaluate this in a prospective trial with each element in a different arm, 
but unfortunately this could not be realized and we had to perform an observational 
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study instead. Despite this limitation however, we have shown that adding elements 
does not always increase the success of a multifaceted implementation strategy. 
We could consider not to include the reimbursement offer and the phone call in a 
future implementation strategy for eSET, leaving a simplified and less expensive 
 implementation strategy. Another methodological limitation could be a bias in the 
selection of couples in the different groups of exposure to strategy elements. 
Some couples could be selected in an exposure group because of their own preference, 
others could be selected because of organisational barriers in the performance of 
the implementation strategy. However, we think that we measured the most important 
possible confounders and that we have corrected for these variables within our multi-
variate analysis.
Conclusion
Our study demonstrated that one element of a multifaceted implementation strategy, 
a decision aid, is probably solely responsible for an increase in eSET use and that 
IVF couples regard this decision aid as important for their decision for the number 
of embryos transferred. Moreover, IVF couples evaluated an additional counselling 
session with the IVF nurse as important and useful for their decision for the number of 
embryos transferred. A reimbursement offer for an extra IVF cycle and an additional 
phone call by the IVF nurse did not increase the eSET use and were evaluated as less 
important strategy elements by the IVF couples.
Practice implications
Our evaluation of a multifaceted strategy to encourage eSET use was able to 
determine that a simplified and less expensive strategy seemed to be just as effective 
for encouraging eSET use compared to a strategy with more elements. However, since 
the couples regarded the support of the IVF nurse as important for their decision for the 
number of embryos transferred and because the multifaceted strategy was focussed 
on empowerment, we suggest to consider combining the decision aid with a support 
session in a future strategy to encourage eSET.
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This thesis aimed on exploring effective ways to encourage the implementation 
of elective single embryo transfer (eSET) to prevent twin pregnancies after in vitro 
fertilisation (IVF). Twin pregnancies result in more complications for both mothers 
and neonates1-9 and due to use of medical facilities also in higher costs compared 
to singleton pregnancies.10,11 Because eSET is an important option to prevent twins 
after IVF, investigating the opportunities to encourage eSET use in clinical practice 
is a valid goal. This thesis described the implementation of eSET according to the 
systematic implementation model of Grol and others.12,13 It included the search for 
determinants as well as for barriers and facilitators for the implementation of eSET and 
the tailoring of a strategy for eSET implementation. Subsequently, the development 
of the main element of a multifaceted eSET implementation strategy, a decision aid 
for the number of embryos transferred, was presented. The final part of this thesis 
focussed on the evaluation of the effectiveness of this strategy in clinical practice, 
through a randomised controlled trial and a process evaluation. In this chapter, the 
main findings of these studies are mentioned and discussed. Next, the most relevant 
methodological issues are reviewed. At the end, recommendations for practice, health 
policy and future research are given.
Main findings
The results of the various studies lead to the following main findings:
•  In 2005, the eSET use in clinical practice among couples with a twin prone profile 
was only 39%.
•  No influential determinants at the patient level for the decision for eSET or DET could 
be identified. 
•  Numerous potential barriers to eSET use among patients and professionals were 
found through qualitative and quantitative exploration. Most frequently mentioned 
barriers to eSET use were suboptimal success rates associated with  cryopreservation, 
not seeing twin pregnancies as a complication, lack of knowledge of couples about 
eSET aspects and twin related risks, a reimbursement system impeding eSET use 
and lack of eSET legislation or protocols.
•  We also identified two factors predicting eSET willingness of IVF professionals. 
With respect to future eSET use, it is important for professionals in which university 
hospital they received their IVF training. Furthermore, a high score for perceived 
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barriers for eSET use with our survey predicted a low willingness to perform eSET. 
•  A multifaceted empowerment strategy, with a decision aid, two support sessions with 
an IVF nurse and a reimbursement offer, effectively encouraged eSET use in clinical 
IVF practice. The strategy increased knowledge, had no substantial side effects, 
reduced costs and could be an important tool to reduce the twin rate after IVF, within 
a setting with patient autonomy. 
•  Couples who had received one or two sessions of support of the IVF nurse did no use 
eSET more often, compared to couples that only received the DA and reimbursement 
offer.
•  Combined with the physician’s advice, the decision aid and the counselling session 
with the IVF nurse were evaluated significantly more important for the couples’ 
decision for the number of embryos transferred, compared to the other strategy 
elements; the telephone call and the reimbursement offer.
Interpretation
The overall results of this project are interesting in several ways. Our multifaceted 
implementation strategy was successful in encouraging eSET use, but some issues 
remain. 
A first issue concerns the barriers to eSET, used to develop the multifaceted 
 implementation strategy. Although providing important insight, many of the identified 
barriers and facilitators for eSET seem related to each-other or are difficult to change. 
We selected barriers for our multifaceted strategy based on feasibility, and with this 
selection unavoidably ignored other barriers with potential for encouraging eSET. 
For instance, the IVF training site of professionals was identified as a predictor for future 
eSET willingness. Enhancement and standardisation of the educational program of 
IVF professionals could therefore have its effect on eSET use. Moreover, improvement of 
the pregnancy rate with cryopreservation is also mentioned as a requirement 
to encourage eSET use, because this will probably make it much easier to 
decide for eSET.18,22 Unfortunately however, both options were not in reach in our 
project. Consequently, it is important to consider that the specific elements of our 
implementation strategy might not be the only option to encourage eSET. Other 
strategies, based on other barriers, might also be effective or even more effective to 
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implement the eSET use. However, a strategy aimed to improve patient knowledge, like 
our decision aid, may have had unknown effects on other barriers as well, for instance 
on the desire of couples for twins or on their unwillingness to perform eSET. 
Second, the eSET rate in the control group of our RCT was 39% and this percentage 
was identical to the eSET use we have measured with our determinant analysis two 
years earlier.19 Therefore, it seems that the eSET use in our region has not increased 
recently and an implementation strategy really is necessary to encourage the eSET 
use. Moreover, the absence of known patient determinants for eSET implies that the 
decision for the number of embryos transferred is probably not based on parameters 
concerning chance of pregnancy. Instead, couples and professionals apparently are 
influenced by barriers for eSET that can be present at many levels. Knowledge of these 
barriers that influence decision-making processes is required to encourage better 
decision options or guideline adherence.20,21
Third, our evaluation shows that a multifaceted strategy, aimed for IVF couples, leads 
to remarkable effects on the actual decision for the number of embryos transferred. 
Such a clear difference in outcome with a patient-directed implementation strategy is 
rare.14,15 Moreover, the magnitude of the difference in eSET use (13%) is noteworthy 
as well. A review by Grimshaw and others described that strategies with educational 
materials have a modest effect on implementation.16 Our results seem more robust. 
The reason for the success of our strategy might be the structural approach for the 
design of the strategy. We have taken advantage of the implementation model of Grol 
and others12,13 and based the elements of the multifaceted implementation strategy on 
our barrier analysis for eSET use.17-18 Moreover, the results of our process evaluation 
are in line with the Grimshaw review, concluding that the effectiveness of multifaceted 
strategies does not increase with the number of elements of strategies.16 
Fourth, it remains immensely important for the effects of this multifaceted strategy 
in what kind of setting the decision for the number of embryos transferred is taken. 
Major differences between countries and even clinics within the same country exist. 
Some centres base the decision for the number of embryos transferred solely on 
clinical parameters, such as female age or the number and quality of the embryos, 
and do not allow patients to have a say in the decision. Other clinics try to fully involve 
patients in the decision and the professional only acts as an advisor for the couple. 
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In between these extremities many variations with more or less patient autonomy 
exist. To be effective, our multifaceted strategy requires absence of compulsory eSET 
legislation and a setting with freedom of choice of couples. In situations without patient 
autonomy, this patient directed empowerment strategy is probably of less or no value 
to encourage eSET. Strategies to encourage eSET should be directed at professionals 
in such settings.
It remains highly debated among professionals if compulsory eSET is a good option 
or not.10,23,24 For maximal eSET use, legislation would be ideal and countries with 
such compulsory eSET rules report high levels of eSET implementation.25,26 However, 
because of the lower pregnancy rate per cycle of eSET compared to DET 27-30, this 
could imply that couples with a less favourable fertility profile pay the price (that is 
through not achieving pregnancy) for the prevention of a twin pregnancy in couples 
with a better fertility profile. As long as this situation exists we should make sure that 
the couple is involved in the decision for the number of embryos transferred. Moreover, 
with our multifaceted strategy we have noticed an increase in couples’ capability to 
take an informed decision. In addition, our RCT shows that patients are willing and 
capable to perform this kind of decisions after information provision within a patient 
friendly format and combined with the support of an IVF nurse. Perhaps, if couples 
are empowered for this decision and comprehend the pros and cons of eSET, the 
strategy is already a success and one could argue about the desirability of further 
encouragement of eSET use. Therefore, it is our opinion that after being thoroughly 
informed, it should be the couple and not the professional that decides for the number 
of embryos transferred. 
Finally, with our multifaceted strategy we increased the eSET use from 39% to 52% of 
the first IVF cycles and from 15% to 26% in the second cycle. The question remains 
if these percentages are acceptable or that we should still endeavour to make more 
couples perform eSET. Among professionals and couples different opinions exist on 
this issue.23,24,31,32 Yet, for one couple the decision for eSET is a logical option, while for 
others this might be completely different. Moreover, is a twin pregnancy rate of 10% 
too high, if these twin pregnancies were all among couples having a less favourable 
chance of pregnancy, or if they occurred in couples that accepted the risks associated 
with twin pregnancies after thorough education? Instead of focussing on a specific 
eSET percentage per clinic or country, it would probably be better to make it easier 
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to choose eSET. Therefore, improvement of eSET results with enhanced prediction 
models or better cryopreservation programs could be important examples to increase 
the eSET, and not per se legislation or compulsory eSET rules.
Methodological issues
Our multifaceted strategy included the now freely available decision aid, support of an 
IVF nurse and the reimbursement offer. Although our process evaluation provided us 
with important insight into the effectiveness of these different elements, we should be 
aware of the difference in methodology compared to a prospective randomised trial. 
Only with such a study design, comparing the effects of all elements in different arms, 
strong conclusions about the effects of each individual element can be drawn. However, 
even within this methodological limitation, we can come to prudent conclusions. With 
respect to the reimbursement offer, we have noticed limited interest and low actual use 
(currently 3 out of 139 couples). Yet, it remains to be seen if this result will be the same 
in countries with less financial welfare or with IVF not covered by health insurance.33 
Moreover, recently the price per IVF cycle in the Netherlands has increased from 1500 
to approximately 2700 Euro and in light of the recent financial crisis we cannot be sure 
that our results regarding the reimbursement will be applicable in the future as well. 
Another issue is that the follow up of our trial had finished before all couples had 
finished with all their IVF cycles. At the beginning of their IVF treatment, couples might 
think very differently about the decision for the number of embryos transferred (and 
the reimbursement offer) compared to when they are faced with a failed last IVF cycle. 
For the same reason, we should be careful with the interpretation of the results of 
the Decision Evaluation Scale. Although we could not identify differences in levels of 
satisfaction-uncertainty or of decision control levels, it remains to be seen if this lack 
of difference would persist in the future if couples, who took full responsibility of the 
decision for the number of embryos transferred, finally end up with a less desirable 
outcome. 
A further issue regarding methodology concerns the hypothetical setting of our 
barrier analysis. It remains possible that some influential barriers impeding eSET 
 implementation were not reported by couples or physicians because they provided 
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socially desirable replies. Examples of this phenomenon could be that professionals 
claim not to worry about bad publicity if their pregnancy results would deteriorate or that 
couples mention not to desire twins, because they are afraid to tell us they actually do.31 
We could consider to explore the barriers for eSET use in an anonymous setting, 
but since our analysis identified numerous barriers and facilitators comparable with 
previous literature10,20,23,24,32,33 and since we were able to design an effective 
 implementation strategy based on these barriers, this should probably not be a major 
concern. 
A last methodological issue concerns the determinant analysis we have performed. 
We could not identify influential determinants for the decision for the number of embryos 
transferred among the clinical fertility parameters of the couples. However, this does 
not imply that determinants for eSET or DET are not present, because we have only 
evaluated parameters in the IVF databases. On the contrary, it is likely that such 
predictors are present at other domains. For instance, receiving IVF from a specific 
clinic or physician could enhance the chance to perform eSET, compared to couples 
receiving IVF elsewhere. If such determinants are identified, these determinants can be 
used in future eSET strategies and therefore be important for eSET implementation.
Implications
Implications for practice
This project presents a multifaceted strategy to encourage eSET use after IVF. Because 
the strategy was effective to encourage eSET, without substantial side effects or higher 
costs, it could be an important tool to reduce the twin rate after IVF. Moreover, the 
couples’ capability to take an informed decision was stimulated with the strategy and 
this by itself could be mentioned as a success. We have observed a higher eSET use 
in the group of participants that only received the decision aid and the accompanying 
reimbursement offer. This was in contrast with couples who received an additional 
counselling session and a phone call from the IVF nurse. Consequently, after omitting 
the less effective strategy elements, only the decision aid for the number of embryos 
transferred remains (www.umcn.nl/IVF-decisionaid).  Implementation of this reduced 
strategy could therefore be as simple and inexpensive as to hand out the decision aid 
or to make it available on the internet. However, to be successful, our strategy probably 
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requires an involved couple and a setting with patient autonomy. The participating 
couples’ considered the counselling session with the IVF nurse as important for their 
decision for the number of embryos transferred. Therefore, depending on if a patient 
centred view (with optimal empowerment) or societal point of view (with focus on twin 
prevention) is chosen, one could still consider providing the information in the decision 
aid accompanied with thorough decision support.
Implications for health policy
When a couple undergoes IVF treatment, many decisions have to be taken, for instance 
on the indication for IVF with or without intracytoplasmic sperm injection or about the 
dose of gonadothrofins for ovarian hyper stimulation. However, none of these decisions 
has such direct consequences for the (quality of) life of the couple as the decision 
for the number of embryos transferred. This decision for eSET or DET could be the 
difference between becoming pregnant or not, but also between having a healthy baby 
or a less positive outcome. For professionals as well as policy makers, it is important 
to consider that these direct consequences are always for the couple to bare. In our 
opinion, couples are very well able to comprehend this decision as long as they are 
provided with the right information within a patient friendly format. Therefore, policy 
makers should ensure that couples are provided with the appropriate information, in a 
balanced and patient friendly way. Moreover, we would advise to involve the couple in 
the decision for the number of embryos transferred, and to refrain from legislation or 
compulsory protocols regarding eSET or DET. 
Implications for future research
The results of our study are promising and raise some important research questions. 
First it would be worthwhile to evaluate the effects of the decision aid in other 
settings and countries. After a necessary adaptation to local IVF results, it would 
be very interesting to observe the effects of the decision aid in settings with other 
cultural backgrounds, different financial welfare or among populations who are less 
accustomed  to patient autonomy. Moreover, our design of the decision aid allows 
a straightforward adjustment to a web-based format. This format would enable an 
interactive communication process with the decision aid, providing tailored information 
per couple. For instance, the couple could enter female age and parity and the web 
based tool subsequently would provide them specific chances for success or risks for 
certain complications. Therefore, we would suggest to examine the preferences and 
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possibilities for a web based format of the decision aid, especially since IVF couples are 
frequent internet users and report high satisfaction with empowerment via internet.34,35
With respect to the effectiveness of the specific elements of our randomised trial, it 
would be worthwhile to evaluate the effects of the decision-aid and reimbursement 
offer (and preferably the other elements of the strategy as well) in a prospective trial 
with one element in each arm. This will provide us with robust evidence, necessary 
to come to solid conclusions about the effectiveness of each specific element of our 
multifaceted strategy on the eSET use in clinical practice. 
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Chapter 1
The focus of this thesis is on exploring effective ways to encourage the  implementation 
of elective single embryo transfer (eSET) to prevent twin pregnancies after in vitro 
fertilisation (IVF) treatment. Twin pregnancies result in more complications for both 
mothers and neonates and due to use of medical facilities also in higher costs 
compared to singleton pregnancies. Chapter one describes the necessity for twin 
prevention through eSET use after IVF and explains the structured approach of this 
thesis.
For couples of reproductive age, subfertility is an important health problem. Many 
couples seek medical attention for subfertility and are assisted to conceive. In vitro 
fertilisation, including intracytoplasmic sperm injection, is an important treatment 
option for subfertile couples and is often the final possibility to start a family. Roughly 
a quarter of all pregnancies after IVF consist of twins. Although these twin pregnancies 
may be experienced as a success by some couples and professionals, they could also 
be considered as a side effect or even a complication of IVF. With twin pregnancies, 
mortality and morbidity levels are elevated for both the mother and neonates, 
compared to singleton pregnancies. The long term consequences of the twin related 
complications vary, but may result in life-long negative impact on the quality of life. To 
prevent twin pregnancies after IVF, couples and professionals could decide to transfer 
only one embryo. This use of eSET will reduce the incidence of twin pregnancies to 
0-1%. However, eSET might result in a lower pregnancy rate per IVF cycle as well. 
Therefore, the decision for eSET will reduce the risk of twin pregnancies but could also 
imply an increased probability to finally end up with no pregnancy at all.
In most IVF clinics in the world, the decision for the number of embryos is taken in a 
decision-making process between the IVF physician and the couple. Depending on the 
setting of the IVF treatment, this couple could have more or less influence on the final 
decision for number of embryos transferred. In the majority of these decision-making 
processes, eSET is not the option of preference. In 2004, the single embryo transfer 
rate in Europe was only 19% of all IVF cycles. In this thesis the systematic approach 
of Grol and others was used to attempt to encourage the implementation of eSET in 
clinical practice. This mainly involved the decision-making process for the number of 
embryos transferred after IVF. 
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Chapter 2
This chapter describes our evaluation of the decision for the number of embryos 
transferred among a twin prone population in 2005, and the search for determinants 
for the decision for eSET or double embryo transfer (DET) among these couples. 
In many European clinics, it is common practice that the couple is somehow involved 
in the decision for the number of embryos transferred. If we want to reduce the twinning 
rate through a higher use of eSET, we need to obtain insight into the decision-making 
process of the couple, and identify which determinants are related to the choice 
for eSET and DET. We therefore performed a retrospective study on 477 twin prone 
couples at two Dutch IVF centres. We collected data on possible objective patient 
determinants, and a multivariate logistic regression analysis was used to determine 
the impact of these determinants on the decision for eSET or DET. The results of our 
evaluation revealed that of the twin prone couples, 61% opted for DET in their first IVF 
cycle. Within the multivariate analysis, two objective patient determinants acted as a 
risk factor for the choice of DET: a lower number of available embryos (p=0.03) and 
a previous ongoing pregnancy after IVF (p=0.04). However, the explained variance of 
these two determinants was only 3%. Further research is therefore necessary to identify 
barriers and facilitators for eSET use at both the level of the couples and clinicians. 
Chapter 3
For the implementation of eSET we can expect numerous potential barriers at many 
levels. Because of all these barriers, it will be necessary to design a thorough strategy 
to implement eSET successfully in daily practice. This implementation strategy should 
be based on the most influential barriers for eSET and these barriers could exist at 
different levels. This chapter gives an overview of potential barriers for eSET, according 
to four theoretical domains of implementation theory and in accordance with literature 
on assisted reproductive technology. It was demonstrated that numerous barriers can 
exist at four different domains; characteristics of eSET itself, characteristics of the IVF 
professionals, characteristics of the couple undergoing IVF and characteristics of the 
context of the IVF treatment. Moreover, it became apparent that to develop a strategy 
to encourage eSET in our specific clinical setting, it was necessary to explore the actual 
barriers and facilitators among our patients and among Dutch IVF professionals.
Chapter 4
To obtain true insight into the barriers for eSET use in our specific setting, we performed 
Summary
171
an exploratory investigation at both the level of couples and IVF professionals. 
This chapter describes this qualitative exploration for actual barriers for eSET. 
We performed explorative semi-structured interviews among Dutch IVF professionals 
and patients. The interviews were based on two theoretical models and were carried out 
among 19 Dutch IVF professionals and 20 couples who had just undergone IVF or were 
on the waiting list for IVF.  With the interviews, we identified a wide variety of factors, 
potentially influencing eSET use: 37 with the professionals and 26 among the patients. 
Examples of factors mentioned by both patients and professionals were: uncertainty 
about the eSET technique, couples’ lack of knowledge about essential eSET aspects, 
absence of a reimbursement system which favours eSET, inadequate options to select 
couples suitable for eSET and inferior cryopreservation success rates. However, to 
estimate the actual impact of the identified barriers and facilitators for eSET use, a 
quantitative confirmation and assessment of the magnitude of the effect is necessary. 
Chapter 5
The aim of this chapter was to quantify the barriers, found in chapter 4, among IVF 
professionals and to identify predictors of professionals’ willingness to perform eSET. 
To do this, we conducted a quantitative study in two ways. First, we determined which 
of the factors found in our previous qualitative study were most frequently perceived 
as barriers to eSET use. Second, to interpret these perceived barriers within the whole 
spectrum of the IVF treatment, we also measured characteristics of the professionals 
and their clinics. We performed a national survey among all Dutch IVF professionals, 
consultant gynaecologists and fertility doctors. In total, 107 professionals participated 
in our survey. The most frequently mentioned barriers to elective SET use were 
suboptimal success rates associated with cryopreservation (96%), not seeing twin 
pregnancies as a complication (79%) and lack of a SET protocol (78%). A multivariate 
analysis identified two variables that seem to predict the professionals’ willingness 
to perform eSET: university hospital of the initial fertility training (P< 0.01) and high 
domain scores of perceived barriers, e.g. professionals’ attitudes and skills (P < 0.01). 
The explained variance of these two variables was 25%. This insight could be critical in 
terms of increasing the use of eSET with an implementation strategy. 
Chapter 6
Based on the identified barriers, we developed a multifaceted strategy to empower 
patients for the decision about the number of embryos transferred. This strategy 
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consisted of a decision aid, support of an IVF nurse and reimbursement of an 
additional IVF cycle for couples for whom the decision for eSET caused a reduced 
chance of pregnancy. Chapter six describes the development of the main element of 
the multifaceted implementation strategy for eSET implementation. The decision for the 
number of embryos transferred should ideally be taken in a shared decision-making 
process with an educated and empowered couple that takes their own preferences 
into account for the decision. With our previous exploration it became clear that 
both professionals and patients agree that those requirements were not present in 
IVF care. Moreover, lack of knowledge of couples about eSET aspects was identified 
as important barriers for eSET use. Therefore, we decided to develop a decision aid 
(DA) for the decision for the number of embryos transferred. The DA’s development 
consisted of a literature search, establishment of the format, and a pilot test among 
IVF patients with questionnaires. One Cochrane review and 34 articles were selected 
for the DA’s content. In the DA, information was presented in text, summaries, tables, 
figures and through a combined with an interactive worksheet. The DA complies with 
almost all criteria of the International Patient Decision Aid Standards. The pilot test 
revealed that the DA was positively reviewed by patients and professionals and that it 
is acceptable for use in clinical practice. Physicians and researchers can use the DA 
without restrictions in clinical IVF practice or for research related to decision-making. 
Chapter 7
The multifaceted strategy consisted of: an evidence-based decision aid, support of 
an IVF nurse (both by a counselling session and a telephone call) and reimbursement 
of an additional IVF cycle for couples for whom the decision for eSET caused a 
reduced chance of pregnancy. Aim of chapter seven was to evaluate the effects of 
this multifaceted empowerment strategy on the actual number of embryos transferred. 
In addition, we evaluated the impact on the decision-making process and on costs 
related to the strategy. We performed a randomised controlled trial (RCT) to compare 
the effects of the multifaceted strategy versus no strategy and included 308 couples 
on the waiting list for IVF. After the first IVF cycle, 52% of the couples in the intervention 
group chose eSET, as did 39% in the control group (p<0.05) and after the second 
IVF cycle the eSET use was 26% versus 15% (p=0.15). The proportion of couples in 
the intervention group who wanted to decide for the number of transferred embryos 
themselves (with the physician only as their advisor) increased from 77% to 90%, 
while this percentage remained at 73% in the control group (p=0.02). Couples in the 
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intervention group had a better knowledge and reported a better informed decision 
(p=0.03), but no significant differences between the two groups were observed in 
anxiety levels or frequency of subclinical depression. After computing all costs of 
this trial, mean total savings in the intervention group were calculated to be €117·10 
per included couple. The results of the randomised controlled trial illustrate that a 
multifaceted empowerment strategy can effectively encourage eSET use in clinical IVF 
practice. The strategy increased knowledge, had no substantial side effects, reduced 
costs and could therefore be an important tool to reduce the twin rate after IVF. 
Chapter 8
The results of our RCT are promising, but the question remains if every strategy element 
equally attributes to the effectiveness of the multifaceted implementation strategy. 
It is common with the execution of an implementation strategy with multiple elements 
that it is not always completely carried out as planned. Therefore, couples in our RCT 
may not have been exposed to all strategy elements. Chapter eight evaluated the 
relation between eSET use and exposure to the different elements of the effective 
multifaceted strategy. Additionally we determined the couples’ experiences with these 
elements, because negative experiences could prohibit the future implementation of 
effective strategy elements. An observational study was performed in 222 couples and 
a multivariate regression analysis was used to determine the influence of the specific 
elements on the decision for the number of embryos transferred. We evaluated the 
experiences of couples with every strategy element with questionnaires. Couples who 
had received the support of the IVF nurse did no use eSET more often, compared to 
couples that only received the DA and reimbursement offer. Regarding the couples’ 
experiences, we found that the reimbursement offer and the phone call were regarded 
as less important by the couples for their decision for the number of embryos transferred, 
compared to the decision aid, the counselling session and the physician’s advice 
(p < 0,001). Therefore, our evaluation revealed that a simplified strategy seems just 
as effective for encouraging eSET use compared to a multifaceted strategy. However, 
since the couples regarded the support of the IVF nurse as important for their decision 
for the number of embryos transferred and the multifaceted strategy had empowerment 
as a focus, we suggest to consider combining the decision aid with a support session 
in a future strategy to encourage eSET. 
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Chapter 9
Chapter nine contains the general discussion. The main findings of the studies 
performed are summarized and the results of our RCT are discussed in light of the 
literature about other implementation studies. A clear difference in outcome with only 
a patient-directed implementation strategy, as was seen with our strategy, is rare. 
Moreover, the magnitude of the difference in outcome is noteworthy as well, because 
usually strategies with educational materials have a modest effect on implementation. 
The results of our process evaluation of the multifaceted strategy are in line with the 
literature, concluding that the effectiveness of strategies does not increase with adding 
elements. 
This chapter also discusses issues that remain after our project. This mainly concerns the 
selection of the barriers for our multifaceted strategy. With this selection we unavoidably 
had to ignore other barriers with potential for encouraging eSET. For instance, the IVF 
training site of professionals was identified as a predictor for future eSET willingness. 
Enhancement and standardisation of the educational program of IVF professionals 
could therefore have its effect on eSET use. Unfortunately however, taking care of this 
kind of barriers was not in reach in our project. Moreover, the major influence of the 
setting of the IVF treatment is discussed. To be effective, our multifaceted strategy 
requires absence of compulsory eSET legislation and a setting with freedom of choice 
of couples. In other situations, this patient directed empowerment strategy is probably 
of less or no value to encourage eSET. 
The general discussion ends with recommendations for clinical practice, policy makers 
and future research. The results of our process-evaluation suggest that for maximal 
results with respect to eSET use, only the freely available decision aid for the number 
of embryos transferred seems to be enough to increase the implementation of eSET. 
Implementation of this strategy could therefore be very straight forward. However, 
depending on if a patient centred view (with optimal empowerment) or societal point 
of view (with focus on twin prevention) is chosen, one could still consider providing 
the information in the decision aid accompanied with thorough decision support of the 
couple. With regard to health policy, our results demonstrate that couples are very well 
able to comprehend the decision for the number of embryos transferred. We would 
therefore advise to always at least involve the couple in the decision for the number of 
embryos transferred and to refrain from legislation or compulsory protocols regarding 
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eSET or DET. With respect to future research it would be interesting to evaluate the 
decision aid in other settings and to examine the possibilities for a web based format 
of the decision aid.
Chapter 10
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Hoofdstuk 1
Het doel van dit proefschrift is om te onderzoeken of er effectieve manieren zijn om 
bij reageerbuisbevruchting, oftwel in vitro fertilisatie (IVF), het terugplaatsen van één 
embryo, ‘elective single embryo transfer’ (eSET), te stimuleren. Het terugplaatsen van 
twee embryo’s leidt namelijk tot veel tweelingzwangerschappen. Deze gaan gepaard 
met meer complicaties vergeleken met éénlingzwangerschappen, zowel voor moeder 
als voor de kinderen. Ook brengen tweelingzwangerschappen hogere kosten met 
zich mee. Hoofdstuk 1 beschrijft waarom preventie van tweelingen, door gebruik van 
eSET, nodig is en legt een gestructureerde aanpak voor om het stimuleren van eSET 
te kunnen onderzoeken. 
Voor paren met kinderwens is onvruchtbaarheid een ingrijpend probleem. Veel 
van hen worden uiteindelijk pas zwanger na toepassen van een vruchtbaarheids-
bevorderende behandeling. Voor deze paren is IVF een belangrijke behandelmogelijk-
heid en vaak de laatste optie om zwanger te kunnen worden. Ongeveer een kwart 
van alle zwangerschappen die tot stand komen door middel van IVF zijn tweeling-
zwangerschappen. Hoewel men soms geneigd is om een tweelingzwangerschap als 
een succes te beschouwen, kunnen tweelingzwangerschappen ook worden betiteld 
als een bijwerking, of zelfs als een complicatie van IVF. Bij tweelingzwangerschappen 
is namelijk de kans op sterfte en ziekte, voor zowel moeder als de kinderen, hoger 
ten opzichte van éénlingzwangerschappen. De ernst van de complicaties varieert, 
maar kan levenslange negatieve consequenties hebben voor de kwaliteit van leven. 
Om te voorkomen dat een tweelingzwangerschap ontstaat na IVF, kunnen paren en 
hun behandelaar ervoor kiezen om slechts één embryo terug te plaatsen. Bij het 
toepassen van IVF met eSET daalt de kans op een tweelingzwangerschap tot 0-1%. 
Een nadeel van eSET is echter dat per IVF behandelcyclus de kans op zwangerschap 
lager is dan bij een cyclus waarbij twee of meer embryo’s worden teruggeplaatst. 
De beslissing om één embryo terug te plaatsen verlaagt dus de kans op complicaties 
bij tweelingzwangerschappen, maar verhoogt ook het risico dat uiteindelijk helemaal 
geen zwangerschap zal ontstaan.
De beslissing over het aantal embryo’s dat zal worden teruggeplaatst bij een IVF 
behandeling vindt in de meeste klinieken plaats via een gezamenlijk beslisproces van 
het paar en hun IVF behandelaar. Het hangt van de setting van de behandeling af (zoals 
in welk land of in welke kliniek de IVF behandeling plaatsvindt) hoeveel inspraak het 
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paar daadwerkelijk in deze beslissing heeft. Op dit moment wordt er in de meerderheid 
van de gevallen niet voor eSET gekozen. In 2004 werd in Europa namelijk slechts 
bij 19% van alle IVF cycli één embryo teruggeplaatst. In dit proefschrift wordt een 
systematische aanpak toegepast om te proberen het gebruik van eSET in de klinische 
praktijk te stimuleren. Deze systematische aanpak betreft met name het beslisproces 
over het aantal embryo’s dat wordt teruggeplaatst bij een IVF behandeling. 
Hoofdstuk 2
In dit hoofdstuk wordt het onderzoek beschreven naar de stand van zaken vóór aanvang 
van de implementatiestudie, met name hoe vaak één of twee embryo’s werden terug-
geplaatst bij paren met een verhoogde kans op het krijgen van een tweeling. Verder 
werd gekeken naar de aanwezigheid van mogelijke factoren bij deze paren, die de 
beslissing voor het terugplaatsen van één (eSET) of twee embryo’s, ‘double embryo 
transfer’ (DET) zouden kunnen voorspellen. Aangezien het in veel Europese klinieken 
gebruikelijk is dat paren in ieder geval enige invloed hebben op het aantal embryo’s 
dat wordt teruggeplaatst na IVF, is het verkrijgen van inzicht in dit beslisproces en het 
identificeren van deze factoren essentieel om in een later stadium het aantal tweelingen 
na IVF te kunnen verminderen. Deze studie is uitgevoerd bij 477 paren die in 2005 een 
eerste IVF behandelcyclus ondergingen van een eerste of volgende IVF behandeling. 
Het ging om paren die werden behandeld in twee Nederlandse IVF centra. Het bleek 
dat 61% van de paren bij hun eerste IVF cyclus koos voor DET. Twee objectieve patiënt 
gerelateerde factoren bleken voorspellend voor deze keuze: een lager aantal embryo’s 
dat beschikbaar was voor terugplaatsen (p=0.03) en een succesvolle voorgaande IVF 
behandeling (p=0.04). Aangezien met deze factoren slechts 3% van de terugplaat-
singen van twee embryo’s voorspeld kunnen worden, is aanvullend onderzoek naar 
belemmeringen en stimuli voor het toepassen van eSET, bij zowel patiënten als IVF 
behandelaren, noodzakelijk. Dit is beschreven in de hoofdstukken 3, 4 en 5. 
Hoofdstuk 3
Voordat eSET op grotere schaal kan worden toegepast, zullen hoogstwaarschijnlijk 
vele belemmeringen op meerdere terreinen moeten worden overwonnen. Hiervoor is 
een gestructureerde aanpak nodig. Deze aanpak zal moeten beginnen met de inven-
tarisatie van deze belemmeringen. In dit hoofdstuk is aan de hand van theoretische 
modellen uit de literatuur een overzicht gepresenteerd van mogelijke belemmeringen 
voor het gebruik van eSET in de dagelijkse praktijk. Het blijkt dat er meerdere potentiële 
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belemmeringen voor eSET bestaan op vier verschillende terreinen: de eSET techniek 
zelf, de IVF behandelaren, de paren die IVF ondergaan en kenmerken van de context 
waar de IVF behandeling plaatsvindt. Het is noodzakelijk om actuele, werkelijke 
belemmeringen te identificeren bij Nederlandse IVF paren en behandelaren voordat 
een effectieve methode voor het stimuleren van eSET gebruik kan worden ontworpen. 
Hoofdstuk 4
Om inzicht te verkrijgen in de werkelijke belemmeringen voor eSET gebruik, is een 
explorerend onderzoek uitgevoerd. Deze kwalitatieve exploratie bij Nederlandse 
IVF paren en behandelaren, door middel van semigestructureerde interviews, wordt 
beschreven in hoofdstuk vier. De interviews werden afgenomen bij 20 Nederlandse 
IVF paren die onlangs IVF hadden ondergaan of op de wachtlijst stonden om IVF te 
ondergaan en 19 behandelaren. De inhoud van de interviews werd gebaseerd op twee 
theoretische modellen. Door middel van de interviews werden bij de behandelaren 37 
belemmeringen voor eSET geïdentificeerd en bij de patiënten 26. Voorbeelden van 
belangrijke belemmeringen die genoemd werden bij zowel behandelaren als patiënten 
zijn: onzekerheid over het effect van eSET gebruik, gebrek aan kennis van IVF paren 
over essentiële aspecten van eSET, het ontbreken van een vergoedingssysteem dat 
eSET stimuleert, gebrek aan goede voorspellende modellen om de juiste paren voor 
eSET te selecteren en te lage zwangerschapscijfers na cryopreservatie van embryo’s. 
Echter, voordat de impact van de geïdentificeerde belemmeringen voor eSET gebruik 
kan worden bepaald is het noodzakelijk om de resultaten van deze kwalitatieve 
exploratie ook kwantitatief uit te drukken. 
Hoofdstuk 5
In dit hoofdstuk wordt de impact van de gevonden belemmeringen bij IVF behandelaren 
vastgesteld en gezocht naar voorspellers voor de bereidheid van IVF behandelaren om 
eSET toe te passen. Allereerst is bepaald welk van de items, die werden gevonden 
bij de voorgaande kwalitatieve exploratie, het meest als belemmeringen voor eSET 
werden ervaren. Vervolgens zijn, om deze belemmeringen te interpreteren in het 
complete spectrum van de IVF behandeling, ook de persoonlijke kenmerken van de 
deelnemende IVF behandelaren en hun klinieken bepaald. Voor deze studie zijn alle 
IVF behandelaren van Nederland benaderd; gynaecologen en fertiliteitartsen. In totaal 
namen 107 behandelaren deel aan dit vragenlijstonderzoek. De meest genoemde 
belemmeringen waren: te lage zwangerschapscijfers na cryopreservatie van embryo’s 
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(96%), een tweelingzwangerschap niet als complicatie zien (79%) en afwezigheid van 
een eSET protocol (78%). Door middel van meervoudige analyses zijn twee factoren 
geïdentificeerd die de bereidheid voorspelden om eSET toe te passen. De eerste 
is het universitair ziekenhuis waar de behandelaar de IVF opleiding had doorlopen 
(p< 0.01). De tweede voorspeller was een hoge vragenlijst score bij een aantal 
behandelaar gerelateerde belemmeringen voor eSET gebruik, zoals bijvoorbeeld de 
attitude over eSET en specifieke vaardigheden (p<0.01). Met deze twee variabelen is 
het mogelijk 25% van de bereidheid van behandelaren voor het gebruik van eSET te 
voorspellen. 
Hoofdstuk 6
Naar aanleiding van de resultaten uit de hoofdstukken 3, 4 en 5 is een strategie 
ontwikkeld om de IVF paren beter te ondersteunen bij hun keuze voor het aantal terug 
te plaatsen embryo’s en daarmee de keuze voor eSET te stimuleren. Deze strategie 
bestond uit een keuzehulp, ondersteuning van een IVF verpleegkundige en een 
financiële vergoeding van een extra IVF cyclus bij paren die na eSET niet zwanger waren 
geworden. Hoofdstuk 6 beschrijft de ontwikkeling van de keuzehulp (‘decision aid’). 
Idealiter wordt de beslissing voor het aantal terug te plaatsen embryo’s genomen in 
een beslisproces waar het paar en de IVF professional samen aan deelnemen. Hiervoor 
is het belangrijk dat het paar goed op de hoogte is van alle essentiële informatie en 
hun eigen voorkeuren mee kan nemen in de beslissing. Bij de voorgaande analyse 
van belemmeringen voor eSET gebruik, werd duidelijk dat zowel IVF behandelaren als 
paren vinden dat dit op dit moment niet goed het geval is. Sterker nog: gebrek aan 
kennis van IVF paren werd gezien als een barrière voor de keuze voor eSET. Dit was 
de reden om een keuzehulp te ontwikkelen voor de keuze van het aantal embryo’s 
dat wordt teruggeplaatst bij IVF. Het ontwikkelproces voor de keuzehulp bestond uit 
een zoekmethode in de wetenschappelijke literatuur, het vaststellen van een geschikte 
presentatievorm en het uittesten bij enkele IVF paren. Voor de inhoud van de DA 
werden de resultaten van één Cochrane review en 34 artikelen gebruikt. Essentiële 
informatie over het terugplaatsen van één of twee embryo’s wordt in de keuzehulp 
aangeboden door middel van tekst, tabellen en figuren. Verder wordt de informatie in 
de keuzehulp ondersteunt met een interactieve invultabel, die de paren na het lezen 
van de keuzehulp kunnen invullen. De keuzehulp voldoet aan bijna alle criteria van de 
‘International Patient Decision Aid Standards’. Bij de pilot test bleek dat de meerderheid 
van patiënten en behandelaren positief oordeelden over de keuzehulp en dat deze 
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als acceptabel voor de klinische praktijk werd gezien. Andere IVF behandelaren en 
wetenschappers kunnen de keuzehulp momenteel zonder restricties gebruiken in de 
klinische praktijk of voor verder onderzoek.
Hoofdstuk 7
De gecombineerde strategie om eSET gebruik te stimuleren bestond uit een keuzehulp, 
ondersteuning van een IVF verpleegkundige (door middel van een counseling gesprek 
en telefoongesprekken) en een vergoedingsregeling voor paren die na eSET gebruik 
niet zwanger waren geworden. Hoofdstuk zeven beschrijft het effect van deze 
gecombineerde strategie op het aantal embryo’s dat wordt teruggeplaatst. Verder is 
gekeken naar de effecten van de gecombineerde strategie op het beslisproces en 
naar de gerelateerde kosten. Wij voerden een gerandomiseerde, gecontroleerde 
studie uit, met 308 paren die op de wachtlijst stonden voor een IVF behandeling. 
De controlegroep doorliep een standaard IVF behandeling en de interventiegroep 
kreeg daarnaast de verschillende elementen van de gecombineerde strategie 
aangeboden. Van de paren in de interventiegroep koos 52% voor eSET bij hun 1e IVF 
cyclus, vergeleken met 39% in de controlegroep (p<0.05). Bij de 2e IVF cyclus was 
dit 26% versus 15% (p=0.15). Bij paren in de interventiegroep steeg het percentage 
paren dat de beslissing over het aantal terug te plaatsen embryo’s helemaal zelf 
wilde nemen (met hun behandelaar slechts als adviseur) van 77% naar 90%. In de 
controlegroep bleef dit percentage stabiel op 73% (p=0.02). In de interventiegroep 
was sprake van een hoger kennisniveau en een beter geïnformeerde keuze ten 
opzichte van de controlegroep. (p=0.03). Meer informatie leidde niet tot meer angst 
of depressies: er werden geen significante verschillen gezien tussen interventie- en 
controlegroep in angstniveau of de aanwezigheid van (subklinische) depressie. 
Na doorrekenen van alle aan de studie en aan de IVF behandeling gerelateerde kosten, 
bleek dat per paar in de interventiegroep in totaal €117,10 kan worden bespaard ten 
opzichte van paren in de controlegroep. De resultaten van deze studie laten zien dat 
de gecombineerde strategie het eSET gebruik effectief kan verhogen. Daarnaast 
verhoogt de methode het kennisniveau, heeft het geen substantiële bijwerkingen en 
reduceert het de kosten. Aangezien eSET gebruik de belangrijkste manier is om bij IVF 
tweeling zwangerschappen te voorkomen, kan deze strategie wellicht essentieel zijn 
om het aantal tweelingen omlaag te brengen.
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Hoofdstuk 8
Hoewel de resultaten van onze gerandomiseerde, gecontroleerde studie veelbelovend 
zijn, blijft het de vraag welk van de elementen van de gecombineerde strategie het meest 
effectief is. Het komt vaak voor dat bij het uitvoeren van gecombineerde strategieën 
deze niet helemaal worden uitgevoerd zoals was gepland. Het is daarom goed mogelijk 
dat paren die deelnamen aan onze studie niet alle verschillende elementen van de 
strategie hebben ontvangen. Hoofdstuk acht bekijkt de relatie tussen de blootstelling 
van IVF paren aan de specifieke elementen van de gecombineerde strategie en hun 
eSET gebruik. Verder bepaalden wij de ervaringen van de deelnemende IVF paren 
met de elementen van de strategie, aangezien negatieve ervaringen het toekomstig 
gebruik van deze effectieve strategie kan belemmeren. Bij deze observationele studie 
werden 222 paren geanalyseerd. De ervaringen van de paren met de elementen van 
de strategie werden gemeten met behulp van verschillende vragenlijsten. Het bleek 
dat paren die naast het ontvangen van de keuzehulp en het vergoedingsaanbod ook 
ondersteund waren door de IVF verpleegkundige (zowel via het counselinggesprek 
als via het telefoongesprek), niet vaker kozen voor eSET vergeleken met paren die 
alleen de keuzehulp en het vergoedingaanbod hadden gekregen. Wat betreft de 
ervaringen bleek dat zowel de vergoedingsregeling als de telefonische ondersteuning 
van de IVF verpleegkundige als minder belangrijk werden gezien dan de keuzehulp, de 
 counselingsessie met de IVF verpleegkundige en het advies van de eigen behandelaar 
(p < 0,001). Het lijkt er dus op dat een versimpelde uitvoering van de strategie 
met alleen de keuzehulp en vergoedingsregeling even effectief is om eSET te 
stimuleren, vergeleken met de uitgebreidere strategie. Echter, aangezien de paren de 
 counselingsessie met de IVF verpleegkundige als belangrijk voor hun beslisproces 
kwalificeren en aangezien de strategie als doel had om IVF paren te ondersteunen 
bij hun beslissing, zouden wij willen adviseren om in een toekomstige strategie een 
combinatie van keuzehulp met counselingsessie in overweging te nemen.
Hoofdstuk 9
In de discussie van dit proefschrift worden de belangrijkste resultaten van de 
verschillende studies samengevat en de resultaten van onze gerandomiseerde, ge-
controleerde studie besproken in het licht van de bestaande literatuur. Een dergelijk 
duidelijk effect van een zuiver patiënt gerichte strategie, zoals bij onze studie, komt niet 
vaak voor. Het is zeker ook interessant, omdat strategieën met scholing of voorlichting 
normaal gesproken slechts een bescheiden effect hebben. Onze conclusie dat de 
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effectiviteit van een strategie niet noodzakelijkerwijs stijgt met het toenemen van het 
aantal elementen van de strategie, komt overeen met de beschikbare literatuur.
Verder worden in dit hoofdstuk discussiepunten besproken naar aanleiding van onze 
resultaten. Dit betreft bijvoorbeeld de keuze van de specifieke belemmeringen waarop 
onze gecombineerde strategie werd gebaseerd. Het was niet mogelijk om rekening te 
houden met alle relevante belemmeringen voor eSET gebruik. Een voorbeeld daarvan 
is dat de plaats van opleiding van de IVF professional voorspellende waarde had voor 
de bereidheid om eSET toe te passen. Verbetering en standaardisatie van het IVF 
onderwijsprogramma zou dus wellicht een gunstig effect kunnen hebben. Dit was 
echter binnen ons project niet mogelijk. Een ander voorbeeld is de grote invloed van 
de context van de IVF behandeling. Onze strategie zal alleen werkzaam zijn in situaties 
waar geen wetgeving bestaat voor verplicht eSET gebruik en waar paren inspraak 
hebben over het aantal embryo’s dat wordt teruggeplaatst bij hun IVF behandeling.
De discussie eindigt met aanbevelingen voor de klinische praktijk, voor beleidsmakers 
en voor verder wetenschappelijk onderzoek. De resultaten van onze procesevaluatie 
suggereren dat alleen de vrij verkrijgbare keuzehulp al effectief is voor het stimuleren 
van eSET gebruik. Het in gebruik nemen van deze strategie zou dus heel simpel kunnen 
zijn.  Echter, het is nog steeds te overwegen om de keuzehulp te ondersteunen met een 
counselingsessie, afhankelijk van welk perspectief wordt gekozen. Indien men kiest 
voor het directe patiëntenperspectief, waarbij het ondersteunen van het beslisproces 
als doel wordt gezien, kan men de ondersteuning aanbieden. Maar indien gekozen 
wordt voor het maatschappelijk perspectief, waarbij het gaat om preventie van twee-
lingzwangerschappen door middel van het doelmatig stimuleren van eSET gebruik, dan 
is de ondersteuning door een IVF verpleegkundige niet nodig. Wat betreft implicaties 
voor beleidsmakers, laten onze resultaten zien dat paren goed in staat zijn om de 
beslissing voor het aantal terug te plaatsen embryo’s zelf te nemen. Wij willen dan 
ook adviseren om het paar dat IVF ondergaat op zijn minst goed te betrekken bij de 
beslissing voor het aantal terug te plaatsten embryo’s en geen wetgeving te lanceren 
voor verplicht gebruik van eSET of DET. Op het gebied van toekomstig onderzoek is 
het zeer interessant  om het effect van de keuzehulp te evalueren in een andere context 
of land. Ook zou het zeer interessant zijn om de mogelijkheden te exploreren van een 
web-based keuzehulp.
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Het schrijven van een proefschrift is geen ‘walk in the park’. Hoewel het een af en 
toe zeer individualistische aangelegenheid is, was het me zonder de onderstaande 
 personen nooit gelukt om dit manuscript op deze prettige manier af te krijgen. 
Allereerst gaat mijn dank uit naar de paren die, bij hun zeer intensieve IVF behandeling, 
tijd wilden vrijmaken om deel te nemen aan ons onderzoek. Het verzamelen van alle 
gegevens is eigenlijk zonder problemen verlopen en dat kwam ongetwijfeld door de 
inzet en onbaatzuchtigheid van deze paren.
Uiteraard ben ik mijn promotoren en copromotoren grote dank verschuldigd. 
Professor dr. J.A.M. Kremer, beste Jan. Je had al na vijf minuten duidelijk dat je 
met mij in zee wilde gaan en dat vertrouwen heb je altijd gehouden. Jouw losse stijl 
van  begeleiden, waarbij je me vrij liet om zelf te denken, plannen en de route uit te 
 stippelen, heeft me zeer geïnspireerd. Op mijn manier heb ik kunnen opbloeien in jouw 
 ‘vruchtbare netwerk’ en dat zullen hoogstwaarschijnlijk nog velen na mij doen.
Professor dr. R.P.T.M. Grol, beste Richard. De manier waarop je erin slaagde om binnen 
zeer korte tijd steeds tot de kern van de zaak te geraken heeft meerdere malen grote 
indruk op mij gemaakt. Ook had ik, ondanks dat er een enorm aantal onderzoekers 
op de afdeling rondliep, nooit het idee dat er geen tijd voor mij was. De rust en het 
vertrouwen die je aan mij meegaf hebben me steeds zeer geholpen.
Dr. R.P.M.G. Hermens, beste Rosella. Ik zal eerlijk zijn: mij was het nooit gelukt om altijd 
zo vrolijk te blijven bij de ongelofelijke bergen werk die je verzette. Jouw support was 
een continue steun in de rug voor mij, zeker op momenten van tegenslagen. Het was 
heerlijk om even ‘low-profile’ met jou te kunnen sparren en dat zal ik zeker missen.
Dr. W.L.D.M. Nelen, beste Williane. Na een half jaar sloot je je bij ons project aan en 
het effect daarvan werd al snel duidelijk. Hoewel je talloze  vraagtekens, correcties en 
perfectionisme me regelmatig tot wanhoop dreven, staat het buiten kijf dat zonder jou 
het project flink in kwaliteit had moeten inboeten en het ongetwijfeld minder succesvol 
was geweest. 
De leden van de projectgroep moeten hier uiteraard ook genoemd worden: Professor 
dr. Zielhuis, dr. Adang, dr. Stalmeier en dr. Wetzels. Het was een voorrecht om in dit 
indrukwekkende multidisciplinaire team te kunnen brainstormen over dit project. Ik heb 
op een zeer prettige manier van uw verschillende expertises kunnen gebruikmaken en 
daar heb ik veel van geleerd.
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Mijn dankbaarheid gaat ook uit naar mijn stagiaires Leonie Jansen en Ilse Kreuwel. 
Beiden hebben door grote zelfstandigheid en inzet tijdens hun stage een publicatie 
mede mogelijk gemaakt. Dat Ilse dit in een later stadium nogmaals kwam doen als 
eerste auteur en nu zelfs haar eerste stappen als onderzoeker zet (nota bene op een 
terrein dat door mij is verkend) vervuld mij met veel trots.
Zonder de tomeloze inzet van José Terken en Annelies Pellegrino zat ik waarschijnlijk 
nu nog te ploeteren met de counselinggesprekken en vragenlijsten. Allebei hebben 
 jullie je open gesteld om samen met mij deze klus aan te gaan. Het was mooi om te 
zien dat jullie de zelfstandigheid die we overeen kwamen niet alleen prettig vonden, 
maar ook al snel gebruikten om mij te bedelven met verbetersuggesties, die  onmisbaar 
bleken voor de kwaliteit van het project. 
Het was heel bijzonder om onderzoek te kunnen doen samen met de leden van het 
IVF team in het UMC St Radboud. Alle teamleden, stafleden, embryologen, IVF artsen, 
nurse-practitioners, verpleegkundigen, analisten en secretaresses hebben mij nooit 
een strobreed in de weg gelegd als ik weer eens iets wilde wat eigenlijk niet zo heel 
handig was in de dagelijkse IVF routine. Te weinig heb ik jullie gezegd hoe bijzonder 
prettig dat voor mij is geweest.
Naast de medewerkers van het UMC, zijn er ook personen in de andere klinieken die 
op een bijzonder prettige, onbaatzuchtige manier hebben meegewerkt aan de studie. 
Het gaat dan om Thecla van de Kamp, Marjo Baan, Caroline Leendertz, Paula Boer, 
Marja Harkes, Xandra van Gaal, Nadine Laterveer en Pettie Maas. Ook dienen hierbij 
de gynaecologen dr. van Dam, dr. Scheffer, dr. Scheenjes, dr. van Dop en Prof. dr. Mol 
in dit kader niet vergeten te worden. 
Mijn opleider Prof. dr. Didi Braat ben ik bijzondere dank verschuldigd voor haar steun 
bij mijn wat onhandige privésituatie. Maar bovenal voor haar expliciete vertrouwen in 
mij, op momenten dat ik dat het hardst nodig had. 
Mijn collega onderzoekers bij de gynaecologie; Anika, Angèle, Dennis, Irene, Ineke, 
Inge, Refika, Suzan, Charlotte, Esther, Selma, Gwendolyn, Bea, Wouter, Sabine, Anne, 
Roosmarie, Joris, Elvira, Linda, Eva, Sanne, Hedwig, Channa en Ralph, ben ik  dankbaar 
voor veel gedeeld lief en leed, de eindeloze gesprekken als er even niet gewerkt kon 
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worden en de broodnodige gezelligheid. Voor degenen die nog niet klaar zijn: als het 
mij lukt, dan jullie al helemaal!
Het was voor mij niet alleen op inhoudelijke grond heerlijk om naast de afdeling 
 gynaecologie ook bij IQ Healthcare te kunnen werken. Het gaat in verband met het 
enorme aantal onderzoekers te ver om iedereen te noemen, maar alle junior en senior 
onderzoekers waarmee ik de eer heb gehad samen te werken: bedankt! Een  speciale 
vermelding moet uiteraard gegeven worden aan de onderzoekers van het kennis-
centrum Maartje, Linda en Marc en de collega’s die samen met mij werden ‘verbannen’ 
naar de IQ kelder, maar het daar toch erg gezellig wisten te maken. Ik heb erg genoten 
van jullie gezelschap.
Zonder de dagelijkse cartoons van Fokke en Sukke van Reid, Geleijnse en Van Tol 
(www.foksuk.nl) was mijn promotietraject een stuk saaier geworden. Ook wil ik de 
 auteurs bedanken dat ik enkele cartoons mocht gebruiken in dit proefschrift. Verder 
moeten de geniale stripjes van collega Jorge Cham op www.phdcomics.com niet 
 vergeten worden. Een feest van herkenning voor de promovendus!
Uiteraard verdienen mijn lieve paranimfen een uitgebreide vermelding. Het was voor 
mij als echte Randstedeling echt niet altijd makkelijk om zomaar ineens in mijn eentje 
in Nijmegen te wonen en zonder Irene haar ondersteuning was dat waarschijnlijk erg 
onaangenaam geweest. Bedankt voor het mij op sleeptouw nemen! Marc, als één van 
de eersten kwam ik erachter hoe jij, in tegenstelling tot vele anderen, in elke probleem-
stelling een prachtige kans zag. Wat was het een verademing om met niets anders dan 
een blocnote in de hand een opzet voor de studielogistiek te verzinnen en dan later 
tot de conclusie te komen dat dit gewoon allemaal gelukt was! Het is geen vast geen 
toeval dat deze eigenschap nu door de hele afdeling is herkend en dat je nu spin in 
het web van velen bent!
Lieve Fien, Ed, familie en schoonfamilie, jullie belangstelling en nooit aflatende steun is 
voor mij heel belangrijk geweest. (‘Duurt promoveren ZO lang?’) Ik ben jullie dankbaar 
voor het meeleven bij tegenslagen en het meevieren van alle succesjes.
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Lieve, lieve Linda. We hadden het ons wel wat makkelijker kunnen maken, maar soms 
gaan dingen nu eenmaal niet zoals gepland. Zonder jou was het me in ieder geval 
nooit gelukt. Je was en bent de rust en het licht in mijn leven en ik prijs me gelukkig dat 
het gelopen is zoals het gelopen is.
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Arno van Peperstraten werd op 19 oktober 1977 in het Eudokia ziekenhuis in  Rotterdam 
geboren. Hij doorliep daar ook de Montessori basisschool en het VWO van het 
 Rotterdams Montessori Lyceum. 
Nadat hij de middelbare school had afgerond is Arno begonnen met de studie genees-
kunde aan de Universiteit van Amsterdam. Tijdens deze studie werkte hij meerdere 
jaren als student-assistent bij het blok ‘Mens, medicus en maatschappij’ en deed hij 
zijn wetenschappelijke stage bij de Cochrane Mentrual Disorder and Subfertility Group 
in Auckland, Nieuw-Zeeland. Zijn coschappen sloot Arno af met het tropencoschap in 
Mumias, Kenia.
Na het behalen van zijn artsexamen werkte Arno anderhalf jaar als AGNIO obstetrie 
en gynaecologie, eerst in het Onze Lieve Vrouwe Gasthuis in Amsterdam en later in 
het Medisch Centrum Alkmaar. Aansluitend hierop begon hij als onderzoeker bij de 
pijler voortplantingsgeneeskunde van het UMC St Radboud, hetgeen dit proefschrift 
als resultaat had. 
Na het afronden van zijn promotieonderzoek werkte Arno een half jaar als ANIOS 
 obstetrie en gynaecologie in ziekenhuis St Antonius in Nieuwegein. Sinds 1 juli 2009 is hij 
werkzaam als gynaecoloog in opleiding in het Jeroen Bosch Ziekenhuis in Den Bosch.
Arno van Peperstraten woont samen met Linda de Groot, die hij in het Amsterdamse 
studentenleven heeft leren kennen.
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